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ABSTRACT 
 
The administration of combination antiretroviral therapy (cART) in HIV positive patients has 
shown to cause side histologically observable effects in the pancreas, liver and kidneys. These 
conditions include acute pancreatitis, cellular injury, oxidative stress, hepatotoxicity and 
nephrotoxicity, which presents as inflammation and cellular injury. Melatonin has been 
successful in the prevention and reduction of inflammatory markers, oxidative stress and 
cellular damage, and has been observed as a treatment option in various conditions. The aim 
of this study was to evaluate the observable morphometric changes caused by cART as well as 
the potential therapeutic effects of melatonin on the pancreas, liver and kidney of the control 
(C/ART-), cART (C/ART+), melatonin (C/M+) and cART and melatonin (ART+/M+) groups 
in the absence of HIV in a rat model. 
 
Tissue samples (N=40) of the ventral part of the pancreas, the median lobe of the liver and the 
right kidney male Wistar rats were collected. The blood samples (n=37) were collected from 
the abdominal aorta after euthanasia. Samples of the pancreas, liver and kidney were stained 
with haematoxylin and eosin (H&E) and evaluated for histopathology. The pancreas was 
labelled with anti-insulin and anti-glucagon to determine α- and β-cell areas in the pancreatic 
islets. Blood samples were collected for liver enzyme tests to evaluate hepatotoxicity. The 
kidneys were stained with periodic acid Schiff (PAS) and the area, perimeter, diameter and 
radius of 30 renal corpuscles, with their associated glomeruli and 90 proximal convoluted 
tubules (PCTs) were measured per rat.  
 
The pancreas, liver and kidney showed no significant histologically observable changes in 
histology. The mean islets per mm2 in the pancreas was significantly higher in the C/M- group 
than in the C/ART- and ART+/M+ groups. Melatonin stimulated the abundance of pancreatic 
islets and thus indirectly the availability of α-cells.  The haemoglobin value in the C/ART+ 
group was significantly higher than in the C/ART- group, which indicates that the mechanism 
in which cART increases serum haemoglobin is possibly still active in the absence of immune 
compromise. The C/M+ group showed a decrease in serum lipaemia compared to the C/ART- 
group, due to melatonin’s its inhibitory effect on peroxidation of cellular lipids by free radicals. 
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In the kidneys, all parameters of the renal corpuscle were significantly lower in the C/ART+ 
and C/M+ groups compared to the C/ART- group. In the glomeruli, some parameters were 
significantly lower in the C/ART+ group compared to the C/ART-, C/M+ and ART+/M+ 
groups. The renal space was significantly decreased in the C/ART+, C/M+ and ART+/M+ 
groups. All parameters of the PCTs were significantly decreased in the C/ART+ group 
compared to the C/ART- group. All the components of the nephron were affected by cART, 
which may have caused tubular dysfunction, cellular damage and a decreased estimated 
glomerular filtration rate (eGFR). In conclusion, cART and melatonin each affected the 
histomorphometry of the pancreas, liver and kidney in a rat model without immune 
compromise. This should be considered when medication is prescribed to patients with HIV, 
specifically in patients with susceptibility to renal injury.  
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OPSOMMING 
 
Kombinasie antiretrovirale middels (kART) veroorsaak waarneembare veranderinge in die 
histologie van die pankreas, lewer en niere van menslike immuniteitsgebreksvirus (MIV)-
positiewe patiënte. Hierdie toestande sluit akute pankreatitis, oksidatiewe stres, 
hepatotoksisiteit en toksisiteit van die niere in, wat as inflammasie en sellulêre skade voorkom. 
Melatonien voorkom en verminder inflammatoriese merkers, oksidatiewe stres en sellulêre 
skade en word vir verskeie toestande as behandelingsopsie oorweeg. Hierdie studie het ten doel 
gehad om die waarneembare morfometriese veranderinge in die pankreas, lewer of niere wat 
versoorsaak word deur kART of melatonien te vergelyk tussen ‘n kontrole (K/ART-) groep, 
kART (K/ART+) groep, melatonien (K/M+) groep en ‘n kART en melatonien (ART+/M+) 
groep in die afwesigheid van MIV in 'n rotmodel. 
 
Weefselmonsters (N=40) vanaf die ventrale deel van die pankreas, die mediane lob van die 
lewer en die regter nier en bloedmonsters (n=37) vanaf die abdominale aorta is geneem van 
manlike Wistar rotte. Die pankreas-, lewer- en nierweefsels is deur hematoksilien en eosien 
(H&E) gekleur vir die evaluering van histopatologie. Die pankreas is ook gemerk deur anti-
glukagon en anti-insulien om die α- and β-selle, onderskeidelik, in die pankreatiese eilande te 
identifiseer. Toksisiteit van die lewer is getoets deur die lewerensieme te evalueer. Die niere is 
gekleur deur periodieke suur en Schiff (PAS) om die area, omtrek, deursnee en radius van 30 
renale liggaampies en hul glomeruli, asook 90 proksimale kronkelbuise per rot te meet.  
 
Geen beduidende verskille is waargeneem in die histologie van die pankreas, lewer en nier in 
enige van die vier groepe nie. Die gemiddelde pankreatiese eilandjies per mm2 was beduidend 
hoër in die K/M+ groep in vergelyking met die K/ART- en ART+/M+ groepe. Melatonien het 
die hoeveelheid eilandjies vermeerder en dus indirek die beskikbaarheid van α-selle in die 
pankreas. Hemoglobien in die K/ART+ groep was beduidend hoër as die K/ART- groep, wat 
moontlik aandui dat die meganisme waarmee kART hemoglobien in MIV-positiewe individue 
vermeerder, steeds aktief is in die afwesigheid van immuniteitsgebrek. Die lipiedinhoud in die 
bloed van die K/M+ groep was beduidend laer as in die K/ART+ groep, wat kan aandui dat 
melatonien lipiedafbraak, wat deur vrye radikale gestimuleer word, onderdruk. 
Al die komponente van die renale liggampies was beduidebd laer in die K/ART- en K/M+ 
groepe in vergelyking met die K/ART- groep. In die glomeruli, is verskeie komponente 
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beduidend verlaag in die K/ART+ groep in vergelyking met die K/ART-, K/M+ en ART+/M+ 
groepe. Die renale spasie was ook beduidend kleiner in die K/ART+, K/M+ en ART+/M+ 
groepe in vergelyking met die K/ART- groep. Al die komponente van die proksimale 
kronkelbuise was beduidend laer in die K/ART+ groep in vergelyking met die C/ART- groep. 
Al die komponente van die nefron is deur kART beïnvloed, hetsy deur tubulêre disfunksie of 
sellulêre skade, wat kan lei tot ‘n verminderde beraamde glomerulêre filtrasietempo (bGFT). 
Ten slotte het cART en melatonien elk die histomorfometrie van die pankreas, lewer en nier in 
'n rotmodel sonder immuniteitsgebrek verander. Dit moet in ag geneem word wanneer 
medikasie voorgeskryf word aan pasiënte met MIV, spesifiek in pasiënte wat sensitief is vir 
nierbesering. 
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CHAPTER 1 INTRODUCTION 
1.1 BACKGROUND 
 
Antiretroviral therapy (ART) has proven to be effective in reducing mortality and morbidity in 
individuals positive for human immunodeficiency virus (HIV) (Max and Sherer, 2000; 
Sulkowski, 2004; Mouly et al., 2006; Brown et al., 2010). Viral suppression and a decrease in 
opportunistic infections are associated with the use of ART (Kim and Rutstein, 2010; Kabbara 
and Ramadan, 2015). Combination ART (cART) regimens has improved medication adherence 
among HIV positive individuals due to the simplified single-tablet design (Bobek et al., 2010; 
Deeks and Perry, 2010; Casado et al., 2015). OdimuneTM (the generic version of Atripla®), 
which is used in South Africa (SA), is one of the latest examples of the latter and consists of 
Tenofovir Disoproxil Fumarate (TDF), Efavirenz (EFV) and Emtricitabine (FTC) (Kabbara 
and Ramadan, 2015).  
 
Despite the continuous development of medication to improve adherence, patients are reluctant 
to adhere to treatment regimens because of the severe side effects that accompanies ART use 
(Max and Sherer, 2000). Metabolic alterations observed with the use of cART includes weight 
gain leading to obesity, increase insulin secretion and glucose uptake in cells causing insulin 
resistance and diabetes (Guzik et al., 2006; Barbosa et al., 2013). Additional histological side 
effects of cART in the pancreas includes pancreatic toxicity, which may include pancreatitis, 
steatosis, islet hypertrophy, and alpha- (α) and beta- (β) cell dysfunction, therefore causing 
diabetes (Radogna et al., 2010; Ferreira et al., 2015). The administration of melatonin may 
prevent the necrosis of β-cells and reduce the excessive production of free radicals that is 
associated with diabetes and inflammatory conditions such as acute pancreatitis (Radogna et 
al., 2010; Jaworek et al., 2012). 
 
Hepatotoxicity, hepatitis, hepatic fibrosis and steatosis, are common conditions caused by 
various regimens of cART. Hepatotoxicity is commonly measured by evaluating liver enzymes 
such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (Sulkowski, 
2004; Chang & Schiano, 2007). Melatonin protects against oxidative and inflammatory 
damage in the liver and has been shown to inhibit proliferation and induce apoptosis of 
fibroblasts (Hu et al., 2015). 
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Similarly, cART causes various side effects in the kidneys of HIV positive individuals. 
Nephrotoxicity expressed as degeneration of tubules, loss of brush borders, luminal ectasia, 
thickening of the tubular basement membrane, simplification and dropout of tubular epithelial 
cells and acute renal failure may also occur. Conversely, melatonin prevents the accumulation 
of leukocytes in injured renal tissue. Melatonin reduces lipid peroxidation and protein oxidation 
in the kidneys. The anti-inflammatory properties of melatonin also protect the kidneys against 
fibrosis (Ersoz et al., 2009; Jao & Wyatt, 2010; Hu et al., 2015). 
 
In summary, it is evident that cART causes multiple disruptions in the histology of the 
pancreas, liver and kidneys. As melatonin is proven to eradicate similar disruptions due to its 
anti-inflammatory and antioxidant qualities, it is proposed that melatonin might be a 
therapeutic option for HIV positive patients receiving cART. 
 
1.2 JUSTIFICATION 
 
The prevalence of individuals living with HIV in South Africa is estimated at 6.19 million for 
2015. This is equal to 11.2% of the total population, of which 18.99% and 16.59% is infected 
women and children, respectively (Statistics South Africa, 2014). This substantial number of 
patients puts great strain on South Africa’s health services. 
 
Melatonin is a hormone available in tablet form and is easily accessible as it is both cost 
effective and available without a medical prescription. If proven that melatonin can eradicate 
or improve the majority of side effects caused by ART, it can be administered to improve 
adherence of ART medication and improve the quality of life of HIV positive individuals. 
Ultimately, medication adherence will lead to higher life expectancy, fewer unemployment due 
to medical incompetency and a lower HIV prevalence in SA. By lowering unemployment due 
to medical reasons, unemployment compensation will also be lowered. It will ultimately lessen 
the strain on the health care system in South Africa and create a platform of socio-economic 
growth. 
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1.3 RESEARCH QUESTION 
 
The primary research question was whether cART induces observable morphometric changes 
on the histology of the pancreas, liver and kidneys in a male Wistar rat model and if so, does 
melatonin reduce or eradicate these effects? 
 
1.4 RESEARCH PROBLEM 
 
Melatonin reduces the possible morphometric changes of cART as induced in the pancreas, 
liver and kidneys of the male Wistar rat, due to its scavenging and antioxidant properties.  
 
1.5 HYPOTHESES 
 
Null hypothesis: Neither cART nor melatonin will cause histological observable changes in the 
pancreas, liver and kidney between four male Wistar rat groups: 1) a control group (C/ART-), 
2) a group subjected to antiretroviral treatment (C/ART+), 3) rats that received melatonin 
treatment (C/M+) and lastly, 4) a group that received melatonin and has been subjected to ART 
(ART+/M+). 
 
Alternative hypotheses: 
a) Histological observable changes will be observed in the pancreas, liver or kidney due 
to cART between the four rat groups. 
b)  Histological observable changes will be observed in the pancreas, liver or kidney due 
to melatonin between the four rat groups. 
 
1.6 AIM 
 
This randomised control study (RCS) aimed to evaluate the observable morphometric changes 
of melatonin and cART on the pancreas, liver and kidney of the C/ART-, C/ART+, C/M+ and 
ART+/M+ groups. In addition to morphometric measurements, the general structure of the 
pancreas, liver and kidney was evaluated for histopathology whilst evaluating melatonin as 
treatment option.  
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1.7 OBJECTIVES 
 
• To compare the area and number of pancreatic islets per surface area between the fore 
mentioned treatment groups using morphometric measurements.  
• To compare the area of α-cells that labelled positive with anti-glucagon between the 
fore mentioned treatment groups using morphometric measurements. 
• To compare the area of β-cells that labelled positive with anti-insulin between the fore 
mentioned treatment groups using morphometric measurements. 
• To classify observable histopathology in the pancreas, liver and kidney as possibly 
induced by cART using semi-quantitative scaling methods.  
• To classify observable cellular changes in the pancreas, liver and kidney as possibly 
induced by melatonin using semi-quantitative scaling methods.  
• To determine hepatotoxicity by liver enzyme tests, specifically AST and ALT, on 1 ml 
blood serum samples. 
 
1.8 KEY TERMINOLOGY 
 
cART: The use of cART in the study will refer to OdimuneTM as used in South Africa as 
treatment for HIV positive patients receiving combination therapy. 
 
Pancreatic islets: The islets of Langerhans will be termed pancreatic islets.  
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CHAPTER 2 LITERATURE REVIEW 
 
2.1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
 
Globally, 36.7 million individuals are living with human immunodeficiency virus (HIV) as 
estimated in 2016, with an incidence of 1.8 million. An estimated 25.5 million (69%) of these 
individuals reside in sub-Saharan Africa (UNAIDS, 2016). In South Africa (SA), the Western 
Cape has the lowest percentage of HIV positive individuals (6.6%), whereas Kwazulu Natal 
has the highest (18.0%), as seen in Figure 2.1. Less than 10% of the population in the Western 
Cape, Northern Cape and Limpopo have a HIV, whereas the Eastern Cape, North West, Free 
State, Gauteng, Mpumalanga and Kwazulu Natal have a HIV prevalence above 12%. 
 
 
Adapted from UNAIDS (2016) 
Figure 2.1 Percentages of individuals infected with HIV in 2016 in each province of South 
Africa. 
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In 2016, 19.5 million HIV positive individuals had access to ART (UNAIDS, 2016). However, 
HIV treatment remains a prominent health priority worldwide, and especially in SA.  
 
2.2 ANTIRETROVIRAL TREATMENT (ART) 
 
Undetectable levels of HIV can be achieved by the effective use of ART. Although the virus is 
still present in the body, replication can be suppressed by targeting HIV reverse transcriptase 
and HIV protease (Di Mascio et al., 2009; Deeks & Perry, 2010). By repressing the virus and 
restoring immune function, opportunistic infections are less likely to manifest in the body 
(Fisher et al., 2006). 
 
Antiretroviral therapy can be classified into five groups: 1) nucleoside analogue reverse 
transcriptase inhibitors (NRTIs), 2) non-nucleoside analogue reverse transcriptase inhibitors 
(NNRTIs), 3) protease inhibitors (PIs), entry inhibitors and integrase strand transfer inhibitors 
(INSTIs). When three of these medications are combined it is classified as highly active 
antiretroviral treatment (HAART) or combination ART (cART) (Deeks and Perry, 2010; Tseng 
et al., 2015). Duel NRTI combinations in cART regimens have shown to react positively in 
terms of drug related interactions, patient adherence, toxicity and costs (Manfredi et al., 2001).  
 
2.2.1 OdimuneTM/Atripla® 
 
OdimuneTM (the generic version of Atripla®), manufactured by Cipla, is the cART regimen 
commonly used in South Africa and consists of two NRTIs namely Tenofovir Disoproxil 
Fumarate (TDF) and Emtricitabine (FTC) and one NNRTI namely Efavirenz (EFV). (Amorosa 
et al., 2005). Atripla® is a single tablet that contains 600mg EFV, 200mg FTC and 300 mg 
TDF. The combined dosage proves beneficial in regards to treatment adherence and 
convenience (Deeks and Perry, 2010). These treatments, however, are associated with severe 
side effects (Table 2.1), which may hinder adherence to the medication (Max and Sherer, 
2000).  
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Table 2-1 Summary of common side effects caused by ART and their features 
Condition caused 
by ART 
Features Source 
Acute pancreatitis 
 
Haemorrhage 
Lymphocyte infiltrate 
Necrosis 
Oedema 
(Muñoz-Casares et al., 2006) 
(Barbosa et al., 2013) 
 
Cell injury Apoptosis 
Necrosis 
(Muñoz-Casares et al., 2006) 
(Barbosa et al., 2013) 
Oxidative stress Catalase 
Glutathione peroxidase 
Lipoperoxides 
Reduced glutathione 
Superoxide dismutase 
(Muñoz-Casares et al., 2006) 
(Apostolova et al., 2010) 
(van Vonderen et al., 2010) 
(Dossou-Yovo et al., 2014) 
Hepatotoxicity Elevated transaminases 
Lactic acidosis with hepatic steatosis 
Nodular regenerative hyperplasia  
Portal hypertension  
Steatohepatitis 
(Sulkowski, 2004) 
(Núñez, 2010) 
Tubular 
dysfunction  
in kidneys 
Dilation of proximal tubules 
Glycosuria 
Hyperaminoaciduria 
(Labarga et al., 2009) 
(Lebrecht et al., 2009) 
Nephrotoxicity Degenerative changes in tubular 
epithelial cells 
Fibrosis 
Loss of brush border 
Luminal ectasia 
Tubular basement membrane 
thickening 
(Van Rompay et al., 2004) 
Glomerulonephritis Endothelial proliferation 
Mesangial proliferation 
Thickening of basement membrane 
(Adjene et al., 2011) 
(Young and O’Dowd, 2014) 
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This study focussed on the effects of cART of the pancreas, liver and kidneys as listed in Table 
2.1. 
 
2.2.2 Side Effects of cART on the Pancreas 
 
Evidence of metabolic alteration is associated with the use of ART. This metabolic change may 
lead to increased insulin secretion and glucose uptake of somatic cells, ultimately causing 
diabetes (Barbosa et al., 2013). Side effects of HAART observed in the pancreas include acute 
pancreatitis, pancreatic atrophy, parenchymal steatosis and apoptosis in patients who died of 
acquired immune deficiency syndrome (AIDS). Furthermore, an increase in the number, 
volume and dysplasia of nuclei is associated with the use of cART (Barbosa et al., 2013; 
Oliveira et al., 2014). 
 
As concluded by Jaworek et al. (2005) the extent of pancreatic damage in cases of acute 
pancreatitis (Table 2.1) depends on factors involved in inflammation. Reactive oxygen species 
(ROS) are an active component of inflammatory conditions. In addition, inflammation can be 
associated with multiple aspects of the use of ART, including the prevalence of HIV (Brown 
et al., 2010). Brown et al. (2010) postulated that inflammatory markers are still expressed in 
HIV positive individuals, despite the use of ART. Furthermore, an increase in inflammatory 
markers was noted after 48 weeks of ART in diabetic patients (Brown et al., 2010). 
 
2.2.3 Side Effects of cART on the Liver 
 
Hepatitis, hepatic fibrosis, lactic acidosis with hepatic steatosis, portal hypertension and 
nodular regenerative hyperplasia are common conditions caused by various regimens of cART 
(Sulkowski, 2004; Chang & Schiano, 2007; Núñez, 2010; Neuman et al., 2013). Furthermore, 
Gallien et al. (2015) found that the specific combination of TDF/EFV/FTC caused hepatitis in 
3% of HIV positive patients. Hepatitis C in HIV positive patients markedly increases the liver 
injury induced by cART (Bonacini, 2004). 
 
Combination ART also causes progressive liver damage, which includes portal hypertension 
and nodular regenerative hyperplasia and non-alcoholic steatohepatitis (Núñez, 2010). The 
latter, which can lead to inflammation and fibrosis, occurs via altered lipid and carbohydrate 
Stellenbosch University  https://scholar.sun.ac.za
9 
 
metabolism (Rector et al., 2008; Ingiliz et al., 2009). Efavirenz, specifically, contributes greatly 
to hypercholesterolemia and may cause hyperlipidaemia in patients with HIV (Fisher et al., 
2006; Oliveira et al., 2014). 
 
The prevalence of hepatotoxicity in HIV positive patients on cART is 3-18% (Nunez and 
Soriano, 2005). Clinically, hepatotoxicity is commonly measured by evaluating liver enzymes 
such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (Sulkowski 
2004; Chang & Schiano 2007). Efavirenz, specifically, has shown to elevate AST and ALT 
levels in HIV positive patients (Max and Sherer, 2000). 
  
Bilirubin, haemoglobin and serum lipid tests may interfere with AST or ALT values, if 
elevated. If either of these components are elevated, it can indicate haemolysis of the red blood 
cells (RBCs) (Glick et al.,  1986; Thapa and Walia, 2007). Table 2.2 shows the normal values 
for bilirubin, haemoglobin and serum lipids, as conducted in conjunction with AST and ALT 
tests, and what abnormal values may indicate.  
 
Table 2-2 Normal values and causes of bilirubin, haemoglobin and serum lipid 
interference in AST and ALT levels in rats 
Test Normal 
value 
Clinical cause of elevation Cause of interference 
Bilirubin 0-1 mg/dl Mild elevation: liver disease 
Moderate elevation: Viral 
hepatitis 
Haemolysis 
Ineffective 
erythropoiesis 
Haemoglobin 13.7-16.8 
g/dl 
Necrosis  Haemolysis 
Serum lipids 16-18 mg/dl Accumulation of lipoproteins  Elevated AST & ALT 
AST 74-143 U/L Liver injury Oral gavage 
ALT 18-45 U/L Hepatocyte necrosis, fatty change, 
cirrhosis 
Oral gavage 
AST/ALT  
ratio 
1:1 Ratio > 2: Chronic liver disease 
Ratio > 1: Acute hepatitis or injury 
 
Adapted from Glick et al. (1986); Kannappan et al. (2006); Thapa and Walia (2007); Giknis 
and Clifford (2008) 
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Elevation of bilirubin levels in the blood may be indicative of liver disease or viral hepatitis, 
whereas an elevation in haemoglobin may be caused by necrosis of RBCs. Specifically, an 
increase in ALT indicates hepatocellular membrane injury for example hypoxia, fatty change, 
cirrhosis and necrosis (Thapa and Walia, 2007; Haschek et al., 2009b), whereas an increase in 
AST may indicate liver injury. The latter may increase hours after injury, but ALT can be 
normal for several days after necrosis occurs (Haschek et al., 2009b). Changes in AST are not 
liver specific, due to its high activity in muscle, whereas changes in ALT are considered liver 
specific in rodents, dogs and non-human primates (Haschek et al., 2009b).  
 
An increase in lipoproteins (lipaemia) may also interfere with liver enzyme tests. Lipoproteins 
include chylomicrons, high density lipoproteins (HDL) and low density lipoproteins (LDL). 
(Nikolac, 2014). Tenofovir has shown to decrease cholesterol and triglyceride levels, whereas 
didanosine, stavudine, and zidovudine increase triglycerides in HIV positive patients (Souza et 
al., 2013). An increase in HDL and hypertriglyceridemia have been associated with 
lipodystrophy in HIV positive patients on cART. Lipodystrophy causes fat relocation in the 
body of patients on cART (Roubenoff et al., 2002). Shikuma et al. (2004) found that HIV 
positive patients who have received cART for 16 weeks have higher body weights than patients 
who have not initiated cART.  
 
2.2.4 Side Effects of cART on the Kidneys 
 
Similar to the pancreas and liver, cART causes various side effects in the kidneys of HIV 
positive individuals. Various NRTIs may aggravate renal complications already experienced 
by HIV positive patients, as they are excreted by the kidneys (Max and Sherer, 2000). 
Nephrotoxicity in the form of urolithiasis, acute renal failure, Fanconi syndrome, nephrogenic 
diabetes insipidus (DI) and hypophosphatemia osteomalacia may be experienced in patients on 
cART (Karras et al., 2003; Jao and Wyatt, 2010).  
 
Adjene et al., (2011) found that chronic administration of 600 mg/70 kg efavirenz decreased 
kidney weight and impaired the cellular structure of the renal cortex of Wistar rats after 30 
days. In this study specifically, loss of cell architecture, glomerulonephritis and congested, 
dilated renal spaces were observed. Nephrotoxicity can be observed histologically as 
degeneration of tubules, loss of brush borders, luminal ectasia, thickening of the tubular 
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basement membrane, simplification and dropout of tubular epithelial cells. As tenofovir is 
directly eliminated through the proximal convoluted tubules (PCTs) and glomerular filtration, 
an increase in tenofovir may cause cell injury in the proximal tubules (Jao and Wyatt, 2010; 
Ryom et al., 2012). However, according to Izzedine et al. (2005) normal glomeruli was 
observed in HIV positive patients on cART, whereas the PCTs were damaged due to tenofovir-
induced nephrotoxicity in patients. 
 
Furthermore, the estimated glomerular filtration rate (eGFR) in patients who are already 
exposed to OdimuneTM was found be significantly lower than in HIV positive patients who 
have not started treatment. However, after six months the eGFR of both groups were similar 
(Squillace et al., 2017). It is suspected that TDF causes the decrease in eGFR due to its effects 
on the tubular function (Post et al., 2010; Squillace et al., 2017). According to Post et al. (2010) 
proteinuria was elevated in HIV positive patients on a combination of FTC and TDF, which is 
indicative of altered PCT function. It was postulated that this result was an effect associated 
with altered tubular function, but not injury (Post et al., 2010).  
 
2.3 MELATONIN 
 
Melatonin (N-acetyl-5-methoxytryptamine) is mainly produced by the pineal gland and is 
responsible for the regulation of circadian rhythms in the body. Pinealocytes synthesize 
melatonin from tryptophan in darkness and secretes it immediately. Melatonin synthesis 
decreases with exposure to light or β-adrenergic blockers (Radogna et al., 2010; Acuña-
Castroviejo et al., 2014).  
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Adapted from Tan et al. (2007) 
Figure 2.2 Chemical diagram of a tryptophan and melatonin molecule. 
 
After tryptophan is converted to melatonin (Figure 2.2) through serotonin, it acts on the 
hypothalamus and hypophysis and induces sleep (Radogna et al., 2010; Acuña-Castroviejo et 
al., 2014).  A review by Jaworek et al. (2012) suggests that the enzymes arylalkylamino-N- 
acetyl-serotonin-transferase (AA-NAT) and hydroxyindolo-O-methyl-transferase (HIOMT) 
regulates melatonin synthesis.  
 
Various studies have proven that melatonin is synthesized by tissues other than the pineal gland 
(Radogna et al., 2010; Acuña-Castroviejo et al., 2014). These tissues include the retina, liver, 
kidneys, Harderian gland of the rat, cerebellum, skin, digestive tract and leukocytes. 
Extrapineal melatonin maintains cell homeostasis and is considered to be involved in 
regulatory mechanisms, whereas pineal melatonin is responsible for biological rhythms, anti-
inflammatory and antioxidant properties (Radogna et al., 2010; Acuña-Castroviejo et al., 
2014).   
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2.3.1 Protective action of melatonin  
 
Melatonin has protective and restorative qualities in tissues damaged by renal ischemia-
reperfusion injury, free radical damage in burn patients, major depression, sleep disorders, 
irritable bowel syndrome and migraine (Dolberg et al., 1998; Maldonado et al., 2007; Baykara 
et al., 2009; Hickie and Rogers, 2011; Wilhelmsen et al., 2011). The positive effect of 
melatonin on these conditions are due to the pleotropic nature of this molecule, as it affects 
multiple systems in the body (Diger Hardeland et al., 2010; Radogna et al., 2010). Not only 
does melatonin regulate circadian rhythms, it is also an antioxidant, anti-inflammatory, 
analgesic, radical scavenger and anxiolytic (Nava et al., 2003; Maldonado et al., 2007; Baykara 
et al., 2009; Yousaf et al., 2010) . Table 2.3 outlines some mechanisms in which melatonin 
influences antioxidant action, immune defence, apoptosis and heat shock protein (HSP). 
 
Table 2-3 Protective effects of melatonin 
Protective effect Mechanism 
Antioxidant properties Scavenge free radicals  
Activates antioxidant enzymes 
Influences immune 
system 
Strengthens immune defence 
Inhibits neutrophil infiltration 
Decrease myeloperoxidase (MPO) activity 
Activates/reduces proinflammatory cytokine production 
Controls apoptosis Reduce apoptosis and necrosis of healthy cells 
Induce apoptosis and necrosis of tumour cells 
Stimulates heat shock 
protein (HSP) 
Stimulates HSP, which protects cells in response to increased 
temperature, oxidative stress and inflammation 
Adapted from Baydas et al. (2002); Jaworek et al. (2002); Muñoz-Casares et al. (2006); Joly 
et al. (2010); Leja-Szpak et al. (2010)  
 
As mentioned above (Table 2.3), melatonin scavenges free radicals including reactive oxygen 
species (ROS) and reactive nitrogen species (RNS). At normal physiological levels, ROS 
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causes proliferative and mitogenic activity (Figure 2.3). These low doses of ROS are 
inactivated by antioxidants (such as melatonin) as it is generated. However, in higher doses, 
ROS accumulates, and cells seize division and growth. Ultimately, cell death occurs in the form 
of apoptosis or necrosis (Bergamini et al., 2004). 
 
 
Adapted from Bergamini et al. (2004) 
Figure 2.3 Cellular effects of low, intermediate and high doses of reactive oxygen species. 
 
Melatonin and its second and tertiary metabolites scavenges ROS and RNS (Table 2.3) such as 
hydroxyl radical (•OH), superoxide anion (O-2), hydrogen peroxide (H2O2) and nitric oxide 
(NO·) (Allegra et al., 2003; Reiter et al., 2007; Tan et al., 2015). Melatonin possesses an 
electron-rich aromatic indole ring, which functions as an electron donor, thereby reducing and 
repairing radicals with unpaired electrons (Allegra et al., 2003; Tan et al., 2007). 
 
The anti-inflammatory properties of melatonin vary depending on the stage of inflammation 
that is experienced. In the early phase of inflammation melatonin activates pro-inflammatory 
mediators, whereas melatonin has the opposite effect during chronic inflammation (Table 2.3). 
In addition, the antioxidant characteristics of melatonin acts in the chronic stage of 
inflammation. Melatonin also induces apoptosis with de-regulation of inflammation. This 
hormone thus controls inflammatory markers and mediators to allow it to act specific to the 
conditions in the body as needed for either healing or inflammatory disturbances (Radogna et 
Stellenbosch University  https://scholar.sun.ac.za
15 
 
al., 2010) Specifically, the present study focussed on the effects of melatonin on the pancreas, 
liver and kidney.  
 
2.3.2 Influence of melatonin on the pancreas 
 
Melatonin is thought to affect carbohydrate metabolism, but the mechanism is still unclear. 
Various authors suggest that melatonin causes a reaction similar to insulin and is associated 
with hypoglycaemia and a higher glucose tolerance. Others postulate that melatonin increases 
blood glucose levels and plasma insulin levels (John et al., 1990; Shima et al., 1997; Peschke 
et al., 2006; Cuesta et al., 2013). Pescke et al. (2006) discovered that the β-cells in the pancreas 
have the melatonin receptor (MT) 1, which opposes insulin secretion. Insulin secretion is thus 
decreased at night, when melatonin levels are high and increased in the day, when melatonin 
levels are low (Peschke and Peschke, 1998).  
 
Conversely, Cipolla-Neto et al. (2014) postulated that a decrease in melatonin levels has been 
proven to induce insulin resistance , as insulin secretion is dependent on the circadian rhythm 
of various mammals (Peschke, 2008). Furthermore, ingestion of food causes an increase in 
melatonin in the GIT, which may stimulate the secretion of pancreatic enzymes. This 
mechanism is important in the postprandial function of the exocrine pancreas (Jaworek et al., 
2007). 
 
Although the effect of melatonin on the pancreas is mainly unknown, evidence suggests that 
the administration of melatonin may prevent necrosis of beta cells (Picinato et al., 2002a) and 
reduce free radicals as produced by diabetes and inflammatory conditions (Baydas et al., 2002; 
Radogna et al., 2010). Furthermore, pancreatic regeneration following acute pancreatitis is 
stimulated by melatonin (Sidhu et al., 2009). Melatonin significantly reduces oedema, 
leukocyte infiltration and cell oedema, which are characteristic of acute pancreatitis. It also 
decreases ROS by reducing the products of lipid peroxidation by restoring catalase (CAT) and 
glutathione peroxidase (GSH-Px) (Muñoz-Casares et al., 2006).  
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2.3.3 Influence of melatonin on the liver 
 
Melatonin is thought to increase glycogen levels in the liver and decrease plasma free fatty 
acids. These changes suggests that melatonin affects glycogen storage by altering carbohydrate 
and lipid utilization (Mazepa et al., 1999). Conversely, Fabis et al. (2002) found that high doses 
of melatonin caused an increase in high density lipoproteins (HDL) cholesterol, which suggests 
that there is a fixed effect of melatonin on lipid parameters. An elevation in AST, ALT and 
LDL were measured in rats with hepatotoxic injury. Melatonin decreased these liver enzymes 
and LDL levels significantly (Sigala et al., 2006) 
 
Sigala et al. (2006) discussed the therapeutic value of melatonin in liver injury due to oxidative 
stress. Melatonin inhibits lipid peroxidation in acute liver necrosis by restoring glutathione 
(GSH). In addition, melatonin protects against oxidative and inflammatory damage in the liver 
(Cuesta et al., 2010; Bekyarova and Tzaneva, 2015). Melatonin has been shown to inhibit 
proliferation and induce apoptosis of hepatocellular carcinoma (HCC) cells. This is of 
importance in the present study as cART induces cellular injury (Barbosa et al., 2013). In 
addition, HCC is induced by cirrhosis and steatohepatitis, which are also suspected side effects 
of cART (Carbajo-Pescador et al., 2009; Oliveira et al., 2014). 
 
2.3.4 Influence of melatonin on the kidneys 
 
Melatonin plays a cytoprotective role in the kidneys; preventing accumulation of neutrophils 
in damaged renal tissue (Sener et al., 2002). Melatonin reduces lipid peroxidation and protein 
oxidation in the kidneys which have been exposed to drug-induced nephrotoxicity (Hara et al., 
2001; Sener et al., 2002). Similarly, melatonin protects the kidneys against fibrosis due to its 
anti-inflammatory properties (Ersoz et al., 2009; Hu et al., 2015). 
 
Nava et al. (2003) found that melatonin reduced tubulo-interstitial infiltration of macrophages 
and lymphocytes which presented in hypertensive rats. These immune cells infiltrate the kidney 
when salt-dependant hypertension occurs, whereas melatonin potentially prevents damage to 
the renal tissue by the reduction of ROS and inflammatory markers (Nava et al., 2003). 
Similarly, the antioxidant properties of melatonin were found to ameliorate tubular necrosis 
and nephrotoxicity in rats exposed to high levels of uranium (Bellés et al., 2007).  
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For the purposes of this study, the morphometric characteristics of changes to the pancreas, 
liver and kidney following cART was determined, as this is not well described in the literature. 
Although various semi-quantitative evaluations have been conducted, limited morphometric 
measurements on the changes of the histology of these organs have been reported. Similarly, 
the literature on the biochemical and antioxidant actions of melatonin has been thoroughly 
discussed, but the morphometric changes of melatonin in tissue is lacking. 
 
2.4 HISTOLOGY OF THE PANCREAS 
 
The pancreas is a retroperitoneal accessory digestive gland and is divided into an exocrine and 
an endocrine part. The exocrine portion, which is classified as a branched tubuloacinar gland, 
is responsible for the secretion of digestive enzymes into the duodenum and represents about 
98% of the pancreas in humans (Motta et al. 1997; Johnson, 1991; Kierszenbaum, 2007; Ovalle 
& Nahirney, 2013). In rats, the pancreas can be divided into a duodenal lobe, splenic lobe and 
gastric lobe (Figure 2.4), where the duodenal duct (main distal duct), splenic duct (main 
pancreatic duct) and gastric duct drain, respectively (Baetens et al., 1979; Dolensek et al., 
2015).  
 
 
Adapted from Dolensek et al. (2015) 
Figure 2.4 Diagram showing duodenal, splenic and gastric lobes of the rat pancreas 
 
The exocrine pancreas consists of parenchymal cells namely acinar and ductal cells (Figure 
2.5). The apical portion of pancreatic acinar cells contain zymogen granules, which contain 
digestive enzymes (Kierszenbaum, 2007; Haschek et al., 2009d). 
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Micrograph by Danélle Truter 
Figure 2.5 Rat pancreas showing acinar cells, pancreatic islet with capillaries and 
pancreatic duct (D) stained with H&E. Magnification = 200x; scale bar = 200 µm 
 
The remaining 2% of the pancreas is an endocrine gland composed of the pancreatic islets 
(islets of Langerhans), which produced several hormones responsible for glucose metabolism 
(Motta et al. 1997; Kierszenbaum 2007; Ovalle & Nahirney 2013).  
 
The pancreatic islets consist of four types of endocrine cells: alpha (α) -cells that produce 
glucagon, beta (β) –cells that produce insulin, delta (δ) -cells which secretes gastrin and 
somatostatin and F-cells which synthesize pancreatic polypeptide (PP). In rodents, the β-cells 
are found in the core of the islet, whereas the α-, delta and F cells are arranged around the 
mantle as shown in Figure 2.6A (Kierszenbaum, 2007; Migrenne, 2011). The pancreatic islets 
of rats in the ventral region are considered glucagon- and PP-poor in relation to the dorsal 
region (Baetens et al., 1979). 
Stellenbosch University  https://scholar.sun.ac.za
19 
 
 
Adapted from Migrenne (2011) 
Figure 2.6 Arrangement of endocrine cells in islets of Langerhans of A) mice and B) 
humans. 
 
The distribution of the endocrine cells in human islets is shown in Figure 2.6B. The β-cells are 
mainly present in the core of the islet, with α-cells arranged diffusely around the islet. The δ- 
and PP-cells are arranged around the mantle of the pancreatic islet (Kierszenbaum, 2007; 
Migrenne, 2011). 
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2.5 HISTOLOGY OF THE LIVER 
 
The liver is an accessory organ of the alimentary tract and is responsible for metabolism of 
glucose, proteins and fat, alteration of exogenous substances and formation of bile. The adult 
liver is comprised of 80% parenchyma, which consists of hepatocytes arranged as a maze of 
cellular plates. Stroma composes the other 20% of the organ (Ovalle and Nahirney, 2013).  
 
 
Micrograph by Danélle Truter 
Figure 2.7 Histology of the liver parenchyma with the portal triad stained with H&E. 
CV= central vein, BD= biliary duct, L= lymphatic vessel. Magnification = 200x; scale bar = 
200 µm 
 
The liver has multiple accompanying structures that forms portal triads: each consists of a 
portal vein, hepatic artery and bile duct (Figure 2.7). Connective tissue divides the liver into 
classic hepatic lobules, which are classified as the structural units of the liver (Ovalle and 
Nahirney, 2013).  
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Adapted from Haschek et al. (2009e) 
Figure 2.8 Diagram of a part of the liver lobule illustrating the different zones 
 
The parenchyma of the liver is divided into the periportal, midzonal and centrilobular areas as 
shown in Figure 2.8. 
 
2.6 HISTOLOGY OF THE KIDNEYS 
 
Kidneys are compound tubular glands, which are covered by a capsule of dense connective 
tissue. The outer capsule of the kidney consists of collagen fibres with fibroblasts. The renal 
parenchyma contains tightly packed renal tubules as shown in Figure 2.9.  
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Micrograph by Danélle Truter 
Figure 2.9 Histology of the kidney stained with H&E. Arrows indicate renal corpuscles 
in cortex. Magnification = 100x; scale bar = 500 µm 
 
The functional unit of the kidney is called a nephron and consists of a renal corpuscle, proximal 
tubule, loop of Henle and distal tubule. The renal corpuscle contains a cluster of glomerular 
capillaries in the Bowman’s capsule (Kierszenbaum, 2007).  
 
Figure 2.10 displays a (A) schematic representation as well as a (B) histological representation 
of the components of the renal corpuscle.  
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(A) Adapted from Ovalle and Nahirney (2013); (B) micrograph by Danélle Truter 
Figure 2.10 A) Schematic diagram of the renal corpuscle, B) Histology of the renal 
corpuscle stained with H&E. JG= juxtaglomerular complex, arrow indicates the 
Bowman’s capsule; 400x magnification; scale bar = 100 µm 
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The glomerulus consists of a capillary network, podocytes (epithelial cells) and mesangium. 
Blood enters the glomerulus via the afferent arteriole and it is filtered to form and plasma 
filtrate (ultrafiltrate) which is composed of water, solute and other small molecules (Haschek 
et al.,  2009c; Sands and Veerlander, 2010). The Bowman’s capsule consists of a visceral layer 
(podocytes) and parietal layer of simple squamous epithelium, of which the latter is continuous 
with the PCT (Haschek et al., 2009c; Ovalle and Nahirney, 2013).  
 
The PCT reabsorbs 50-60% of the ultrafiltrate from the glomerulus, which includes water, 
glucose, sodium and amino acids. The pars recta, thin descending, thin ascending and thick 
ascending limbs form the loop of Henle. The loop of Henle generates osmotic pressure via the 
counter-current multiplier system and the distal convoluted tubule (DCT) uses aldosterone to 
reabsorb sodium ions to ultimately dispose of acid in the body (Haschek et al., 2009c; Sands 
and Veerlander, 2010; Ovalle and Nahirney, 2013). 
 
2.7 DIFFERENT FIXATION AND STAINING METHODS  
 
2.7.1 Common fixatives 
 
Proper fixation to stabilize cell morphology and tissue architecture is integral in 
histomorphometric studies. Fixatives can be classified as either denaturing or cross-linking. 
Denaturing fixatives include alcohol-based fixatives and acts by creating hydrogen bonds, 
whereas cross-linking fixatives create covalent chemical bonds between proteins in the 
respective tissue (Howat and Wilson, 2014). Glutaraldehyde, neutral buffered formalin (NBF) 
and paraformaldehyde are classified as cross-linking fixatives. Alcohol-based fixatives has 
shown to create shrinkage of tissue and lysis or swelling of RBCs (Howat and Wilson, 2014).   
 
Formaldehyde has been the golden standard for fixation since the 1900s. Paraformaldehyde 
(PFA) is a polymerized form of formaldehyde, which is methanol-free formaldehyde and is 
commonly used to fixate proteins, peptides and enzymes (Hassel and Hand, 1974). In the 
present study, 4% PFA was used as fixative for all tissues. 
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2.7.2 Haematoxylin and Eosin (H&E) 
 
Haematoxylin and Eosin (H&E) is commonly used for its ability to stain most tissue structures. 
In the present study, Mayer’s Haematoxylin was used, which stains nuclei dark blue/black. 
Eosin stains the cytoplasm of various tissues pink. Erythrocytes, eosinophilic granules, other 
tissue elements stains varying shades of pink (Bancroft and Layton, 2013b). This stain was 
used for the evaluation of histopathology in the pancreas, liver and kidney. The staining 
protocol is outlined in addendum 1.  
 
2.7.3 Periodic acid and Schiff (PAS) 
 
Periodic acid Schiff is used to highlight carbohydrate-rich molecules such as glycogen, 
glycoproteins, and proteoglycans typically found in connective tissue, glycocalyx and basal 
laminae. An important mechanism of PAS is the oxidizing action of periodic acid to bind with 
free •OH groups or amino/alkylamine groups to form dialdehydes. Schiff stains glycogen and 
glycoproteins magenta and nuclei blue (Bancroft and Layton, 2013a; Giri, 2015). This stain 
was used to distinguish between the PCTs and DCTs. Periodic acid Schiff stains the brush 
border of the PCTs and the discernible nuclei of the DCTs. The protocol for PAS is outlined in 
addendum 3. In this study, the stain was used to clearly distinguish between the proximal and 
distal convoluted tubules of the kidney.   
 
2.7.4 Immunohistochemistry 
 
Immunohistochemistry (IHC) is a technique used to visualise an antigen using a labelled 
antibody of that specific antigen. This antigen can be a fluorescent dye, an enzyme, radioactive 
element or colloidal gold. The procedure for IHC includes fixation, antigen retrieval, blocking 
of endogenous enzymes and antibody labelling (Chen et al., 2010). In the present study, 
double-staining was used to label α- and β-cells with anti-glucagon and anti-insulin, 
respectively. The protocol is outlined in addendum 2 and will be discussed in the following 
chapter.  
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CHAPTER 3 MATERIALS AND METHODS 
 
The study consisted of four male Wistar rat groups as indicated in Figure 3.1: 1) a control group 
(C/ART-), 2) a group which received antiretroviral treatment C/ART+), 3) rats that received 
melatonin treatment (C/M+) and lastly, 4) a group that received melatonin and has been 
subjected to ART (ART+/M+) (Figure 3.1).  
 
 
 
Figure 3.1 Design of the experiment consists of four groups; C/ART-, C/ART+, C/M+ and 
ART+/M+. Each group consisted of 10 male Wistar rats. All treatments were 
administered for 8 weeks. 
 
The animal selection and care were conducted by the Division of Medical Physiology, 
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch 
University. Male Wistar rats were housed (maximum of four animals per cage) in a controlled 
environment (temperature: 22°C; humidity: 40%; circadian rhythm: 12 hours of artificial light 
per day). All animals were on a normal rat chow diet for 16 weeks. The rats were 8 weeks old 
(180–200g) when the cART and melatonin treatment was initiated.  
 
The ART was administered in adult male Wistar rats for eight weeks by means of oral gavage. 
The C/ART- and C/M+ groups were also gavage with 1 ml of water (without ART) to ensure 
Stellenbosch University  https://scholar.sun.ac.za
27 
 
that no variation occurred due to the procedure. A generic version of Atripla® (OdimuneTM) 
was used in the fixed dose combination (FDC) of 300 mg TDF, 600 mg EFV and 200 mg FTC. 
The OdimuneTM tablets were crushed and administered according to the rats’ weekly weights. 
Each rat received TDF, EFV and FTC of 25.8 mg/kg/day, 51.6 mg/kg/day and 17.4 mg/kg/day, 
respectively. 
 
The melatonin was administered for eight weeks in the drinking water of the rats. All rats 
received 10 mg/kg/day, depending on the rats’ weight. The average weight of the rats in the 
cage were calculated weekly and multiplied by 0.01 mg/g/day. The melatonin was made up 
two days in advance and administered at the same time every day. The amount of water the 
rats drank were calculated after each day. The following equation was used to determine the 
grams of melatonin needed: 
 
𝑀𝑒𝑙𝑎𝑡𝑜𝑛𝑖𝑛 𝑛𝑒𝑒𝑑𝑒𝑑 (𝑚𝑔)𝑓𝑜𝑟 500 𝑚𝑙
=
[(𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑟𝑎𝑡𝑠 𝑖𝑛 𝑐𝑎𝑔𝑒 ÷ 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑟𝑎𝑡𝑠 𝑖𝑛 𝑐𝑎𝑔𝑒)  × 0.01]
𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑑𝑟𝑎𝑛𝑘 𝑝𝑒𝑟 𝑟𝑎𝑡 𝑝𝑒𝑟 𝑑𝑎𝑦 ÷ 500 𝑚𝑙
 
Equation 1 Calculation of melatonin needed for two days of stock 
 
The melatonin was firstly dissolved in 0.2% ethanol (500 µl) before 500 ml distilled water was 
added.  
 
3.1 TISSUE SAMPLE COLLECTION  
 
Tissue samples (N=40; n=10 per group) of the pancreas, liver, kidney and blood samples were 
obtained after the rats were anesthetized, before 10:00 in the morning, using an intraperitoneal 
injection of 160 mg/kg sodium pentobarbitone into the lower right abdomen and euthanized 
via exsanguination. All rats were weighed with a scale before euthanasia.  
 
Pancreata were isolated by detaching the connective tissue from the stomach to the small 
intestine. Thereafter, the connective tissue was loosened at the caudal end of the large intestine 
as well as the spleen, thus minimalizing the amount of fat retrieved. The duodenal lobe of the 
pancreas was used for analysis. The right median lobe of the liver and the right kidney were 
harvested. All three organs were immediately put in 4% paraformaldehyde (PFA) after 
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retrieval. Blood (approximately 1 ml) was collected after the removal of the heart and placed 
in a Becton Dickinson (BD) vacutainer serum tube.  
 
Ethical approval to use tissue for this study was obtained from the Research Ethics Committee: 
Animal Care and Use of Stellenbosch University (SU-ACUM15-00003-Tissue). 
 
3.2 TISSUE PROCESSING 
 
Tissue samples of the pancreas, liver and kidney were processed in the Histology Laboratory 
located in the Division of Anatomy and Histology, Department of Biomedical Sciences, 
Faculty of Medicine and Health Sciences, Stellenbosch University as described in the following 
subsections. 
 
3.2.1 Fixation 
 
Fixation consists of several chemical events to preserve the tissues by preventing autolysis and 
bacterial attack (Bancroft & Stevens 1990). The tissues obtained for this study was immediately 
fixed in 4% PFA for 24-48 hours after retrieval, after which processing was initiated in the 
Histology laboratory.  
 
3.2.2 Tissue processing 
 
The pancreas, liver and kidney were trimmed to an appropriate size. The excess fat was 
removed from the pancreas before inserting it into an embedding cassette (approximately 3 cm 
x 1 cm). The kidney was cut in cross-section at the pelvis as indicated by Figure 3.2 with a red 
line. Approximately 3-4 mm of the superior and inferior parts of the kidney was cut as indicated 
by the blue lines in Figure 3.2. The kidney (approximately 1 cm x 1 cm) was embedded with 
the pelvis to the bottom of the cassette and the superior and inferior parts towards the top of 
the cassette.  
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Figure 3.2 Diagram showing how the kidney was cut before processing. The red line 
indicates where the kidney was cut at the pelvis. Blue lines indicate how the superior and 
inferior parts of the kidney was cut. 
 
Tissue samples were then processed using a Leica XL automated tissue stainer (Manufacturer 
& Model: Leica St 5010; Serial Number 1732/07.2007). The steps of processing include 
dehydration, clearing and infiltration, where the tissue is put in 70%, 90%, 99%, 99%, 99% 
and 99% alcohol for 15 minutes, 15 minutes, 15 minutes, 15 minutes, 30 minutes and 45 
minutes, respectively. Clearing was done by placing the tissues in xylene for 20 minutes, 20 
minutes and 45 minutes. Wax infiltration was done for 30 minutes, 30 minutes and 45 minutes 
(Rolls, 2017). 
 
3.2.3 Embedding 
 
Paraffin wax, moulds and wax-infiltrated tissues was pre-heated to 60ºC within the Leica 
embedder (Leica EG1160, Cat. No. 038630528). The embedding cassette was filled halfway 
with paraffin wax, after which the tissue was placed into the wax. The cassette was closed and 
set by adding the lid and filling the cassette completely with the paraffin wax. Thereafter, the 
cassette was immediately placed onto an iced surface to set the wax (Bancroft & Stevens 1990).  
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3.2.4 Sectioning 
 
Wax tissue blocks were removed from the mould, after which it was trimmed by a Leica 
microtome (Leica RM2125RT, SMM Instruments, Cat. No. 045737987) to provide a smooth 
surface for cutting. The embedded pancreas tissue was cut into 3 μm sections and the liver and 
kidney were cut into 5 μm sections. Two serial sections were made for the pancreata and 
kidneys, and one section for the liver.  
 
3.2.5 Heating 
 
The specific sections were placed into the water bath (Electrothermal, Cat. No. MH 8501), 
where they were picked up onto a microscope slide at a 45° angle (Bancroft & Stevens 1990). 
One of the three slides of the pancreas were positively charged to enable IHC labelling. The 
tissue was then inserted into a heating oven to enable the slide with the respective tissue to dry. 
 
3.2.6 Staining 
 
The pancreas, liver and kidney sections were stained with H&E (addendum 1) to enable 
histopathology analysis. Haematoxylin and eosin stains the nuclei blue, the cytoplasm pink and 
the red blood cells, eosinophilic granules, other tissue elements varying shades of pink 
(Bancroft and Stevens, 1990).  
 
Additionally, the pancreata were labelled using monoclonal anti-insulin and polyclonal anti-
glucagon. The anti-insulin and anti-glucagon identifies the α- and β-cells in the pancreatic 
islets, respectively. An envision G/2 System/AP, Rabbit/Mouse kit was used for the staining 
as described in addendum 2.  
 
In summary, 3% hydrogen peroxide was used to block tissue against endogenous peroxidase 
activity.  The tissue was then rinsed with both 0.05 M tris buffered saline (TBS) (pH = 7.2) and 
0.1 M phosphate buffered saline (PBS) (pH = 7.2) to maintain a normal pH. Normal goat serum 
(NGS) of a 1:20 dilution was then used for 20 minutes to block non-specific binding of 
subsequent agents. The anti-glucagon antibody (100μl) at a 1:100 dilution was then placed on 
the slides in a moisture chamber for 30 minutes. Biotinylated anti-rabbit immunoglobulin G 
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(IgG) antibody at a 1:200 dilution was placed on the slides for 30 minutes, followed by 
Vectastain® (ABC kit, North America) for 60 minutes to detect an unlabelled primary 
antibody. Then, a chromogen solution (K3468, Dako, North America) with liquid 3’3-
diaminobenzidine (DAB) was placed on the slides for 5 minutes to enhance the staining of the 
tissue. Normal horse serum (NHS) of a 1:20 dilution was added to the slides for 20 minutes in 
the moisture chamber to block non-specific binding of subsequent agents. Thereafter, the anti-
insulin (100μl) of a 1:10 000 dilution was placed on the sections and incubated overnight at 
4°C. The next day, the slides were warmed to room temperature and the Envision™ kit was 
placed on the slides to enable staining of more than one marker. Mayer’s haematoxylin was 
then used to counterstain the tissue for 2 minutes. After the slides dried, a coverslip was added 
with distyrene/plasticizer/xylene (DPX) mounting medium.  
 
In addition to H&E, the kidneys were also stained with PAS (addendum 3). The slides were 
oxidised with periodic acid for 5 minutes and rinsed with distilled water. Schiff’s reagent was 
then placed in the slides for 15 minutes, which was rinsed with lukewarm water. The slides 
were counterstained with Mayer’s haematoxylin for 1 minute and washed in tap water. The 
stained section was covered with a cover slide proportional to its size by using DPX mounting 
medium. In this study, the stain was used to clearly distinguish between the proximal and distal 
convoluted tubules of the kidney (Bancroft and Layton, 2013a; Giri, 2015). 
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3.3 ANALYSES OF PANCREATA, LIVERS AND KIDNEYS 
 
The pancreata, kidneys and livers stained with H&E were screened for any histopathology 
present by the researcher, two histopathologists and a histologist. In addition, two 
interobservers also confirmed the findings. 
 
 
Figure 3.3 Summary of stains and tests for the pancreas, liver and kidney 
 
Furthermore, the pancreata, kidneys and livers were analysed by IHC, PAS and liver function 
tests, respectively, which will be discussed in the following subsections. Figure 3.3 shows a 
summary of the methods for each of the three tissues. 
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3.3.1 Pancreas 
 
The pancreata (N=40) were stained with H&E for histopathology analysis. Inflammatory cells, 
necrosis, loss of cell architecture, swelling of pancreatic ducts and fibrosis were considered. 
The observations were classified as absent (0), mild (1) or moderate (2). 
 
The slides labelled with anti-insulin and anti-glucagon were used to quantify the insulin and 
glucagon secreting cells in the pancreatic islets (Figure 3.4A) (Michels et al., 1986; Elayat et 
al., 1995). To quantify the hormone secreting cells, the whole section of the pancreas was 
scanned with a Nikon Eclipse ProScan microscope at a 100x magnification (10 x objective 
lens). The images were taken with a 15% overlap and was stitched together to form a composite 
image of the tissue. The section area and islets were analysed using the Leica QWin Pro 
(version 3.5.0) software. Firstly, the tissue area on each individual photo was measured and 
added together to provide the complete tissue area for each specific animal. Normalisation of 
the data was ensured with a log transformation because the amount of pancreatic tissue 
retrieved differed per animal. The complete section area was converted from µm2 to mm2 and 
the number of islets per mm2 was then calculated. The area was converted to mm2 to enable 
the comparison of natural numbers rather than a very small number of 10-6. 
 
After the section area was determined, the islets per area were analysed with the 
PancreasIsletMeasurements (v1.1) 13/02/2013.Q5R routine. Each islet was selected, and the 
area of the islet was measured as shown in Figure 3.4B, where the green shows the area of the 
pancreatic islet.   
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Figure 3.4 Examples of measurements of the pancreas in a control rat, including the total 
islet area, α-cell area and the β-cell area. A) Pancreatic islet labelled with anti-insulin and 
anti-glucagon; B) Total islet area = green; C) α-cell area = blue; D) β-cell area = red. 
Magnification = 100x; scale bar = 100 µm 
 
The area labelled with brown, which represents the α-cells, was measured (Figure 3.4C). The 
area selected with blue highlighted the α-cell area. The area labelled red, which represents the 
β-cells, was then measured (Figure 3.4D). Pancreatic islets which were not completely in view 
in the specific photo, were excluded.   
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The measurements were then used to determine each hormone’s fraction per islet area by using 
equation 2 below: 
 
 
𝐻𝑜𝑟𝑚𝑜𝑛𝑒 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 =  
𝐻𝑜𝑟𝑚𝑜𝑛𝑒 𝑎𝑟𝑒𝑎
𝐼𝑠𝑙𝑒𝑡 𝑎𝑟𝑒𝑎
 ×  100 
 
Equation 2 Hormone percentage calculation 
 
In total, 514, 733, 762 and 643 islets were analysed for the C/ART-, C/ART+, C/M+ and 
ART+/M+, respectively.  
 
3.3.2 Liver analyses  
 
The liver was stained with H&E for histopathology analysis. Inflammatory cells, necrosis, loss 
of cell architecture and granular appearance were considered. The observations were classified 
as absent (0), mild (1) or moderate (2). 
 
Blood from the thoracic aorta for liver function tests was collected into a yellow BD vacutainer 
tube. The tube was then place in a centrifuge at 1 300 rpm for 20 minutes and the serum was 
collected and frozen at -80ºC before sending it to the National Health Laboratory Services 
(NHLS) for analysis. 
 
Liver function tests, including AST and ALT, haemoglobin and lipemia (Glick et al., 1986; 
Thapa and Walia, 2007) was done by the NHLS of Tygerberg. The method of analysis is 
outlined in addendum 4. The AST value was divided by the ALT value to determine the ratio 
for each specific animal. 
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3.3.3 Kidney analyses 
 
The kidneys were stained with H&E for histopathology analysis. Inflammatory cells, necrosis, 
loss of cell architecture, vacuolation and swelling of tubules were considered. The observations 
were classified as absent (0), mild (1) or moderate (2). 
 
The kidneys stained with PAS were used for morphometric analyses (Kotyk et al., 2016). Each 
kidney section was scanned with the Nikon automated tissue scanning software at a 200x 
magnification (20x objective lens). The images were taken with a 10% overlap and was stitched 
together to form a composite image of the tissue as seen in Figure 3.5.  
 
 
Figure 3.5 Composite image of the kidney showing the superior, middle and inferior part.  
 
The red line indicates the complete length of the kidney tissue on the specific slide (894.68 
µm). The yellow lines indicate the various parts the kidney tissue was divided into. 
Magnification = 200x; scale bar = 200 µm 
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Thirty renal corpuscles were analysed per animal (10 per part). To randomise the renal 
corpuscles that are analysed, the area of the kidneys was divided into a superior, middle and 
inferior part. Every fifth renal corpuscle was analysed to amount for ten renal corpuscles 
analysed per part. For each renal corpuscle, the following was measured:  
1. Renal corpuscle area  
2. Renal corpuscle circumference 
3. Renal corpuscle diameter 
4. Renal corpuscle radius 
5. Glomerular area 
6. Glomerular circumference 
7. Glomerular diameter 
8. Glomerular radius 
9. Renal space 
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Figure 3.6 Examples of measurements of the kidney of a control rat, including the renal 
corpuscle, glomerulus, PCTs and lumen of the PCTs. A) Renal corpuscle area, diameter, 
perimeter and radius B) Proximal convoluted tubule area with lumen (LPCT), diameter, 
perimeter and radius C) Glomerular area, diameter, perimeter and radius D) Lumen of PCT 
area, diameter, perimeter and radius. Magnification = 200x; scale bar = 50 µm 
 
Figure 3.6A shows measurement of renal corpuscle and 16C measurement of glomerulus. 
 
In addition to the measurements of the renal corpuscles, three PCT’s adjacent to the specific 
renal corpuscles measured, was also analysed (Figure 3.6 B&D). The following was measured 
per PCT: 
1. PCT area 
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2. PCT circumference 
3. PCT diameter 
4. PCT radius 
5. Luminal area 
Th thickness of the PCT (PCT area) were calculated as the PCT area with the lumen (LPCT) 
minus the luminal area. 
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3.3.4 Statistical analyses 
 
All data was statistically analysed by a biostatistician using Microsoft Excel and Statistica 
software (version 13). All p-values smaller than 0.05 were considered significant and p-values 
smaller than 0.01 were considered highly significant. The following tests were used to analyse 
the data: 
 
Mean: The mean or average of a sample is the sum of all the values divided by the amount of 
observations (McKillup, 2012). 
 
Standard error of the mean (SEM): The standard error of the mean is the standard deviation 
(SD) of the dispersal of the sample mean. The SEM increases as the sample size increases, 
which improves the accuracy of the statistic (McKillup, 2012). 
 
Analysis of variance (ANOVA): A single-factor ANOVA is used to compare the means of a 
sample between three or more treatments. A single-factor ANOVA only determines that one 
or more treatment differs from the rest. A multiple-comparison ANOVA identifies which 
treatment differs from the other(s) (McKillup, 2012). 
 
Levene’s Test: A Levene test determines the absolute variation between each duplicate and its 
treatment mean and does a one-way ANOVA on that variation. 
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CHAPTER 4 RESULTS 
 
4.1 BODY MASS 
 
The body mass of the rats was measured before euthanasia was administered. The mean body 
mass of the rats were 297.2 g, where no significant difference (p=0.4) was seen in body mass 
between the four treatment groups (Figure 4.1). The C/ART+ group had the lowest mean body 
mass of 288.6 g and the C/M+ group had the highest mean body mass of 303.3 g.  
 
C/ART- C/ART+ C/M+ ART+/M+
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Figure 4.1 Body mass of the rats did not differ significantly between the four treatment 
groups. 
 
The C/M+ group showed an increased body weight in comparison to the C/ART+ group 
(p=0.1). 
 
299.6 ± 19.8 
288.6 ± 22.9 
295.0 ± 28.6 
303.3 ± 22.7 
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4.2 PANCREAS 
 
Sections of the pancreas were stained using H&E and labelled using monoclonal anti-insulin 
and polyclonal anti-glucagon antibodies. 
 
4.2.1 Histopathology of the pancreas 
 
Sections of the pancreas (n=40) stained with H&E were used for histopathologic evaluation 
and confirmed by the researcher, two histopathologists and a histologist. In addition, two 
interobservers also confirmed the findings. The observations were classified as absent (0), mild 
(1) or moderate (2). Histopathology observed were extremely mild and included proteinaceous 
material outside of the ducts. Furthermore, other incidental findings included mildly and 
moderately active lymph nodes as well as proteinaceous casts.  
 
 
Figure 4.2 Proteinaceous material outside of ducts as indicated by the arrows in a rat 
from the C/ART+ group. Magnification = 100x; scale bar = 200 µm 
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As seen in Figure 4.2, 2.5% (1/40) of the pancreata showed proteinaceous material outside of 
the pancreatic ducts, which was seen in the C/M+ group.  
 
4.2.2 Other findings 
 
Proteinaceous material was seen in the ducts of 21% (8/39) of the pancreata, as seen in Figure 
4.3.  
 
 
Figure 4.3 Proteinaceous material in ducts of all four groups of the pancreas as indicated 
by the arrows. A) C/ART-; B) C/ART+; C) C/M+; D) ART+/M+. Magnification = 100x; scale 
bar =100 µm 
 
The proteinaceous material is observed in all treatment groups as seen in Figure 4.3 A, B, C 
and D. 
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The accompyning lymph tissue outside of the pancreas parenchyma appeared active in 15% 
(6/39) of the pancreata; of which 10% (4/39) were mildy active and 5% (2/39) were moderately 
active. Figure 4.4 shows the included lymph tissue, including lymph nodes and gut-associated 
lymphoid tissue (GALT) in the ART+/M+ group, which appeared mildly active, especially in 
the paracortical area of the lymph tissue.  
 
 
Figure 4.4 Included lymph tissue of ART+/M+ group appears mildly active. Arrows 
indicate the lymphoid tissue. A) The cortical area of the lymph tissue appears mildly active, 
but it does not penetrate the parenchyma. Magnification = 50x; scale bar = 500 µm; B) Included 
GALT (*) appears mildly active, but is well circumscribed. Magnification = 100x; scale bar = 
200 µm C) & D) The cortex of the included lymph tissue appears mildly active. ** indicate 
follicles in cortex. Magnification = 100x; scale bar =200 µm 
 
The groups that had active lymph tissue included C/M+ (3/6), C/ART+ (2/6) and ART+/M+ 
(1/6).  
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4.2.3 Analysis of the pancreatic islets 
 
The pancreatic islets were labelled with monoclonal anti-insulin and polyclonal anti-glucagon 
antibodies, respectively. A total of 1056 pancreatic islets with their accompanying α-cells and 
β-cells were measured in the C/ART- group, 1512 in the C/ART+ group, 1570 in the C/M+ 
group and 1320 in the ART+/M+ group.  The islet cells positive for glucagon (α-cells) labelled 
brown and the cells positive for insulin (β-cells) labelled red (Figure 4.6). Islet numbers were 
normalised to the respective total section areas (mm2). Table 4.1 shows a summary of the 
measurements obtained in the pancreas. 
 
Table 4-1 Summary of the measurements on the pancreatic islets in the pancreas labelled 
with anti-insulin and anti-glucagon ± SD of the four treatment groups. 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same 
letter/s is/are present above each of the groups, there were no significant differences. 
 
No significant difference (p=0.5) was seen in the islet area between the four groups. The mean 
islet areas for the C/ART-, C/ART+, C/M+ and ART+/M+ groups were each 4755.68 µm2, 
4113.95 µm2, 5249.80 µm2 and 4928.76 µm2, respectively.  
Treatment Islets per mm2 Islet area (µm2) α-cell area (µm2) β-cell area (µm2) 
C/ART- 1.53 ± 0.72b 4755.68 ± 1595.80a 443.58 ± 240.66ab 1902.76 ± 1003.85a 
C/ART+ 2.06 ± 0.52ab 4113.95 ± 852.20a 352.71 ± 105.55a 1468.57 ± 343.98a 
C/M+ 2.30 ± 0.69a 5249.80 ± 1738.86a 582.72 ± 311.35b 1838.75 ± 802.11a 
ART+/M+ 1.66 ± 0.55b 4928.76 ± 1919.92a 442.87 ± 171.85ab 1880.72 ± 1021.24a 
Mean 1.89 ± 0.68 4762.05 ± 1574.64 455.47 ± 228.16 1772.70 ± 825.33 
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Figure 4.5  The area of the α- and β-cells did not differ between the four treatment groups. 
The β-cell area (blue line) was higher than the α-cell area (red line) in all four treatment 
groups. Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the 
same letter/s is/are present above each of the groups, there were no significant differences. 
 
As seen in Figure 4.5, in all treatment groups, the α-cell area was smaller than the β-cell area 
with an area mean of 455.47 µm2 α-cells and 1772.70 µm2 β-cells per islet. The α-cell area of 
the C/ART+ group was the lowest with 352.71 µm2 and the α-cell area of the C/M+ group was 
the highest with 582.72 µm2. Post hoc tests showed the α-cell area differed significantly 
(p=0.03) between the C/ART+ and C/M+ groups.  
 
The β-cell area of the C/ART- group was the highest with 1902.76 µm2 and the β-cell area of 
the C/ART- group was the lowest with 1468.57 µm2. Neither the α-cell area (p=0.2) nor β-cell 
area of α-cells and β-cells (p=0.6) showed significant difference between the four groups.   
 
 
 
 α-cell area 
 β-cell area 
 
ab 
ab 
a 
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The mean percentage of α-cells and β-cells of the four treatment groups was 6.57% and 
34.45%, respectively (Table 4.2). No significant difference was observed in either α-cell 
percentages (p=0.8) and β-cell percentages (p=0.8) between the four treatment groups. 
 
Table 4-2  Percentage of α-cell area and β-cell area in the pancreatic islets ± SD of the 
four treatment groups. 
Treatment α-cell percentage β-cell percentage 
C/ART- 6.65 ± 3.14a 36.07 ± 8.63a 
C/ART+ 5.86 ± 2.51a 34.90 ± 7.19a 
C/M+ 6.86 ± 1.97a 33.61 ± 6.49a 
ART+/M+ 6.89 ± 2.26a 33.21 ± 7.30a 
Mean 6.57 ± 2.44 34.45 ± 7.24 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same 
letter/s is/are present above each of the groups, there were no significant differences. 
 
Figure 4.6 shows the α-cell area (brown) in the mantle of the pancreatic islets and the β-cell 
area (red) in the core of the pancreatic islets of the four treatment groups.  
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Figure 4.6 Examples of the islet area and α- and β-cell area of the four treatment groups 
showed no significant differences. The C/M+ group had more islets per mm2 than the 
other groups. A) C/ART- group B) C/ART+ group C) C/M+ group D) ART+/M+ group. 
Magnification = 100x; scale bar = 100 µm. 
 
The mean number of islets observed between the four groups per mm2 was 1.89. The C/ART- 
group had 1.53 per mm2, the C/ART+ group had 2.06 per mm2, the C/M+ group 2.30 per mm2 
and the ART+/M+ group 1.66 per mm2. The number of islets per mm2 differed significantly 
(p=0.03) between the four groups as shown in Figure 4.7.  
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Figure 4.7 The number of pancreatic islets per mm2 differed significantly between the 
treatment groups. Statistical significance (p < 0.05) is indicated by different letters of the alphabet. If the 
same letter/s is/are present above each of the groups, there were no significant differences. 
 
Post hoc analysis showed highly significant difference in the C/M+ group compared to the 
C/ART- (p=0.01) and ART+/M+ (p=0.02) groups.  
 
  
b b 
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4.3 LIVER 
 
Sections of the liver were stained using H&E. Additionally, liver enzymes tests, specifically 
AST, ALT, lipaemia and haemoglobin were done on blood samples. 
 
4.3.1 Histopathology of the liver 
 
Sections of the liver (n=40) stained with H&E were used for histopathologic evaluation and 
confirmed by the researcher, two histopathologists and a histologist. In addition, two 
interobservers also confirmed the findings. The observations were classified as absent (0), mild 
(1) or moderate (2). Histopathology observed was extremely mild and included granular 
appearance of hepatocytes, loss of hepatocyte architecture and lymphocyte infiltration. The 
histopathology observed was expressed as a percentage of the total amount of liver sections 
observed.   
 
The specific histopathology that was seen in the liver included granular appearance, loss of 
hepatocyte architecture and lymphocyte infiltration. Mild granular appearance of hepatocytes 
was observed in 23% (9/40) of livers (Figure 4.8A). Loss of hepatocyte architecture (Figure 
4.8B) and lymphoid infiltration (Figure 4.8C) were seen in 3% (1/40) of the livers, which was 
also classified as mild. Hydropic changes expressed as mild vacuolation (Figure 4.8D) were 
seen in 15% (6/40) of the livers. 
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Figure 4.8 Percentages of the histopathology seen in the liver in the total of four treatment 
groups. No histopathology = 0; mild activity = 1. A) Granular appearance of hepatocytes; B) 
Loss of hepatocyte architecture; C) Lymphocyte infiltration; D) Vacuolation 
 
Granular appearance of hepatocytes was seen in 40% of the C/ART- group, 20% in the 
C/ART+ group, 20% in the C/M+ group and 10% in the ART+/M+ group (Figure 4.9).  
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Figure 4.9 The percentages of the granular appearance of hepatocytes did not differ 
significantly between the four treatment groups. A) C/ART- group; B) C/ART+ group; C) 
C/M+ group; D) ART+/M+ group 
 
The granular appearance of hepatocytes did not differ significantly (p=0.4) between the four 
treatment groups. Figure 4.10B shows an example of  mild granular appearance observed in 
the affected livers in contrast with a normal appearance of the hepatocytes (Figure 4.10A).  
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Figure 4.10 Granular appearance and vacuolation of hepatocytes. A) Normal appearance 
of hepatocytes B) Mild granular appearance of hepatocytes. Arrows indicate vacuoles. 
Magnification =200x, scale bar = 100 µm 
 
The prevalence of vacuolation did not differ significantly between the four treatment groups, 
but showed a trend (p=0.06) between the four treatment groups (Figure 4.11). The C/ART- 
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group had 40% vacuolation, the C/ART+ group 10%, the C/M+ group 10% and the ART+/M+ 
group 0%. Mild vacuolation, as seen in these groups, is indicated in Figure 4.10B.  
 
 
 
Figure 4.11 The percentages of the mild vacuolation of hepatocytes did not differ 
significantly between the four treatment groups. A) C/ART- group; B) C/ART+ group; C) 
C/M+ group; D) ART+/M+ group 
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Figure 4.12 Lymphocyte infiltration in various areas around the central veins of a C/M+ 
liver. CV= central vein; arrows indicate lymphocytes. A) 100x magnification, scale bar = 200 
µm; B) 100x magnification, scale bar = 200 µm; C) 200x magnification, scale bar = 100 µm; 
D) 400x magnification, scale bar = 100 µm. 
 
Lymphocyte infiltration around the central veins was seen in the C/M+ group (Figure 4.12). 
The infiltration was seen around the central veins. 
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4.3.2 Liver enzyme analysis 
 
Blood samples (n=37) were used to do liver function tests, specifically ALT, AST, serum 
haemoglobin and serum lipaemia. Three of the blood samples for the ART+/M+ group could 
not be collected due to an inadequate amount of blood from three of the rats.  
 
Table 4-3 Summary of the values from liver function tests ± SD of the four treatment 
groups. 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
No significant differences were seen in ALT (p=0.83) nor AST (0.61) values between the four 
groups (Table 4.3). The mean of the ALT of the four groups was 60.51, whereas the mean of 
the AST was 184.68. The highest ALT value was 68.14 and the highest AST value was 217.71, 
both in the ART+/M+ group. The AST/ALT ratio was above 2:1 for all groups (p<0.01), with 
the C/M+ group being the highest with 3.32:1. The lowest AST/ALT ratio was 2.92:1 and in 
the C/ART- group. No statistical difference (p=0.51) was, however, observed between the four 
groups for the AST/ALT ratio. 
 
Bilirubin, haemoglobin and lipaemia tests were conducted to determine interference on AST 
and ALT. All bilirubin values were 0 mg/dl. Figure 4.13 and Figure 4.14 shows the serum 
haemoglobin and serum lipaemia values, respectively.  
Treatment ALT  
(U/L) 
AST  
(U/L) 
AST/ALT  
ratio 
Haemoglobin  
(g/dl) 
Lipaemia  
(mg/dl) 
C/ART- 62.40 ± 6.44a 181.50 ± 107.14a 2.92 ± 0.60a 50.90 ± 27.91b 12.00 ± 7.23a 
C/ART+ 54.40 ± 0.55a 160.80 ± 75.50a 3.02 ± 0.70a 98.00 ± 65.29a  8.33 ± 2.24ab 
C/M+ 59.40 ± 9.52a  188.60 ± 85.60a 3.32 ± 0.76a 66.20 ± 30.26ab  6.90± 2.42b 
ART+/M+ 68.14 ± 2.50a  217.71 ± 61.65a 3.30 ± 0.73a 92.17 ± 39.93ab  9.67 ± 1.97ab 
Mean 60.51 ± 9.84  184.68 ± 84.49 3.13 ± 0.69 74.46 ± 45.51  9.20 ± 4.61 
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Figure 4.13 Serum haemoglobin value differed significantly between the C/ART- group 
and C/ART+ group. Statistical significance (p < 0.05) is indicated by different letters of the alphabet. If the 
same letter/s is/are present above each of the groups, there were no significant differences. 
 
The serum haemoglobin (Figure 4.13) and lipaemia (Figure 4.14) values could be determined 
for 35 animals; C/ART- (n=10), C/ART+ (n=9), C/M+ (n=10) and ART+/M+ (n=6). The 
combined treatment effect was not significant (p=0.09), but showed a trend (Table 4.3) between 
the four treatment groups. However, post hoc analysis showed the C/ART- group had the 
lowest haemoglobin value at 50.90 and differed significantly (p=0.02) with the C/ART+ group, 
which had a haemoglobin value of 98.00. A trend (p=0.07) was also seen between the C/ART- 
and ART+/M+ groups with a haemoglobin value of 92.17 for the latter. 
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Figure 4.14 Serum lipaemia value differed significantly between the C/ART- group and 
C/M+ group. Statistical significance (p < 0.05) is indicated by different letters of the alphabet. If the same 
letter/s is/are present above each of the groups, there were no significant differences. 
 
The serum lipaemia value did not differ significantly between the four treatments, but showed 
a trend (p=0.08) (Figure 4.14). Post hoc analysis showed that the C/ART- group, which had a 
lipid value of 12.00, differed highly significantly (p=0.01) with the C/M+ group, which had a 
lipid value of 6.90. The C/ART- and C/ART+ groups also showed a trend (p=0.08) with a lipid 
value of 12.00 and 8.33, respectively. 
  
C/ART- C/ART+ C/M+ ART+/M+
Treatment
2
4
6
8
10
12
14
16
S
er
u
m
 l
ip
ae
m
ia
 v
al
u
e 
(m
g
/d
l)
a
ab
b
ab
Stellenbosch University  https://scholar.sun.ac.za
59 
 
4.4 KIDNEY 
 
The kidneys were stained using both H&E and PAS.  
 
4.4.1 Histopathology of the kidney 
 
Sections of the kidney (n=40) stained with H&E were used for histopathologic evaluation and 
confirmed by the researcher, two histopathologists and a histologist. In addition, two 
interobservers also confirmed the findings. The observations were classified as absent (0), mild 
(1) or moderate (2). Histopathology observed were mild and moderate hydropic changes, which 
included swelling of proximal and distal convoluted tubules and vacuolation of proximal 
convoluted tubules. The amount of histopathology observed were expressed as a percentage of 
the total amount of kidneys observed.  
 
Mild swelling of the PCTs and DCTs were observed in 45% (18/40) of the kidneys (Figure 
4.15A), which was accompanied by 55% (22/40) of PCTs and DCTs which presented with 
vacuolation (Figure 4.15B).  
 
 
Figure 4.15 Percentage of A) swelling and B) vacuolation seen in the kidneys in the total 
of four treatment groups. No histopathology = 0; mild activity = 1; moderate activity = 2. 
 
Swelling of the PCTs and DCTs showed no significant differences (p=0.2) between the four 
groups, but as seen in Figure 4.16, the C/ART- and C/ART+ group varies from the C/M+ and 
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ART+/M+ groups. The prevalence of swelling in the C/ART- and C/ART+ group was 40% 
and 20%, respectively, whereas it was 60% in both the C/M+ and ART+/M+ groups.  
 
 
Figure 4.16 Percentage of mild swelling seen in the kidneys did not differ significantly 
between the four treatment groups. A) C/ART-; B) C/ART+; C) C/M+; D) ART+/M+ 
 
Of the 54% (21/40) affected kidneys which presented with vacuolation in the PCTs and DCTs, 
50% (20/40) were classified as mild and 5% (2/40) as moderate.  
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Figure 4.17 Percentage of mild and moderate vacuolation seen in the kidneys did not 
differ significantly between the four treatment groups. A) C/ART-; B) C/ART+; C) C/M+; 
D) ART+/M+ 
 
Vacuolation of the PCTs and DCTs showed no significant differences, but showed a trend 
(p=0.1) between the four groups. Figure 4.17 shows the C/ART- and C/ART+ group varies 
from the C/M+ and ART+/M+ groups. The prevalence of vacuolation in the C/ART- and 
C/ART+ group was 38% and 30%, respectively, whereas it was 70% in both the C/M+ and 
ART+/M+ groups. 
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4.4.2 Analysis of renal corpuscles with accompanying proximal convoluted tubules 
 
The kidneys (n=40) stained with PAS were used for histomorphometric measurements of the 
renal corpuscle, glomerulus and proximal convoluted tubules. Figure 4.18 shows staining of 
the kidney with PAS to distinguish between the DCT and PCT.  
 
 
Figure 4.18 Serial sections of slides stained with H&E and PAS. PAS distinguishes 
between the DCTs and PCTs. A&B shows no discernible nuclei or brush border as stained 
with H&E. C & D shows discernible nuclei (*) of the DCT and the brush border (arrows) of 
the PCT as stained with PAS. The DCT also has a larger lumen than the PCT. A & C 
magnification = 100x; scale bar = 100 µm. B & D magnification = 200x; scale bar = 100 µm. 
 
Each kidney was divided into three sections and the area, diameter, perimeter and renal space 
of 10 renal corpuscles per area with their glomeruli was measured. The area, diameter, 
perimeter and PCT thickness of three proximal convoluted tubules adjacent to the associated 
renal corpuscle was measured. A total of 300 renal corpuscles, glomeruli and renal spaces and 
900 PCT’s were measured per treatment group.   
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4.4.2.1 Renal corpuscle  
 
A summary of the measurements of the renal corpuscle is outlined in Table 4.4.  
Table 4-4 Summary of the measurements of the renal corpuscle of the four treatment 
groups ± SD. 
Treatment Area (µm2) Diameter (µm) Perimeter (µm) Radius (µm) 
C/ART- 9381.97 ± 3435.95a 107.44 ± 20.11a 355.76 ± 64.76a 53.72 ± 10.05a 
C/ART+ 7672.45 ± 2989.24b 97.08 ± 18.59b 323.23 ± 60.17b 48.54 ± 9.30b 
C/M+ 8239.66 ± 2879.72b 100.12 ± 19.89b 333.74 ± 64.27b 50.06 ± 9.94b 
ART+/M+ 8390.83 ± 3528.32ab 101.68 ± 20.40ab 336.70 ± 66.84ab 50.57 ± 10.45b 
Mean 8421.23 ± 3274.84 101.58 ± 20.09 337.36 ± 66.84 50.72 ± 10.11 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
The area of the renal corpuscle differed significantly (p=0.02) between all treatment groups 
(Figure 4.19A). Specifically, the C/ART- differed highly significantly from the C/ART+ 
(p<0.01) and significantly from the C/M+ (p=0.03) group. A trend (p=0.06) was seen between 
the C/ART- and ART+/M+ groups. The renal corpuscle area of the C/ART- group was the 
highest at 9381.97 µm2 and the C/ART+ group the lowest at 7672.45 µm2.  
 
The diameter of the renal corpuscle differed highly significantly (p=0.01) between all treatment 
groups (Figure 4.19B). Post hoc analysis showed that the C/ART- group’s renal corpuscle 
diameter was the highest at 107.44 µm and differed highly significantly from the C/ART+ 
(p<0.01) group, which had the lowest renal corpuscle diameter of 97.08 µm. The C/ART- group 
differed significantly from the C/M+ (p=0.02) group, whereas a trend (p=0.07) was seen 
between the C/ART- and ART+/M+ groups. 
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Figure 4.19 The area, diameter, perimeter and radius of the renal corpuscle differed 
significantly between the four treatment groups. Statistical significance (p < 0.05) is indicated by 
different letters of the alphabet. If the same letter/s is/are present above each of the groups, there were no 
significant differences. 
 
The perimeter of the renal corpuscle differed highly significantly (p=0.01) between the four 
treatment groups (Figure 4.19C). Post hoc tests showed that the C/ART- group had the highest 
renal corpuscle perimeter of 355.76 µm and differed highly significantly (p<0.01) from the 
C/ART+ group with a renal corpuscle perimeter of 323.23 µm and from the C/M+ group (0.03), 
which had a renal corpuscle perimeter of 333.74 µm. 
 
The radius of the renal corpuscle differed highly significantly (p=0.01) between the four 
treatment groups (Figure 4.19D). The C/ART- group, which had the highest renal corpuscle 
radius, differed significantly from the C/ART+ (p<0.01), C/M+ (p=0.02) and ART+/M+ 
(p=0.04) groups. 
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4.4.2.2 Glomerulus 
 
A summary of the measurements of the glomerulus is outlined in Table 4.5.  
 
Table 4-5 Summary of the measurements of the glomeruli of the four treatment groups ± 
SD 
Treatment Area (µm2) Diameter (µm) Perimeter (µm) Radius (µm) 
C/ART- 5512.37 ± 2519.59a 81.41 ± 19.83a 363.38 ± 120.47a 40.70 ± 9.91a 
C/ART+ 4670.64 ± 2079.68b 75.25 ± 16.91b 346.48 ± 103.19a 37.62 ± 8.46b 
C/M+ 5519.37 ± 2370.49a 81.75 ± 18.59a 354.19 ± 105.50a 40.88 ± 9.29a 
ART+/M+ 5501.12 ± 2505.78a 81.20 ± 19.63a 357.73 ± 113.90a 41.28 ± 13.44a 
Mean 5300.86 ± 2400.28 79.90 ± 18.94 355.44 ± 111.01 40.12 ± 10.54 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
The area of the glomerulus showed a trend, but did not differ significantly (p=0.06) between 
the four treatment groups (Figure 4.20A). Post doc tests, however, showed that the C/ART+ 
group differed significantly with the C/ART- group (p=0.03), C/M+ (p=0.03) and ART+/M+ 
(p=0.03) groups. The C/ART+ group had the lowest glomerular area of 4670.64 µm2, whereas 
the C/M+ group had the highest of 5519.37 µm2. 
 
The diameter of the glomerulus showed a trend, but did not differ significantly (p=0.09) 
between the four treatment groups (Figure 4.20B). Post doc tests, however, showed that the 
C/ART+ group differed significantly with the C/ART- group (p=0.04), C/M+ (p=0.03) and 
ART+/M+ (p=0.05) groups. The C/ART+ group had the lowest glomerular diameter of 75.25 
µm, whereas the C/M+ group had the highest of 81.75 µm. 
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Figure 4.20 The area, diameter, perimeter and radius of the glomerulus differed 
significantly between the four treatment groups. Statistical significance (p < 0.05) is indicated by 
different letters of the alphabet. If the same letter/s is/are present above each of the groups, there were no 
significant differences. 
 
The perimeter of the glomerulus did not differ significantly (p=0.8) between the four treatment 
groups (Figure 4.20C). The C/ART- group had the largest perimeter and the C/ART+ group 
the smallest of 363.38 µm and 346.48 µm, respectively. The perimeter mean of the glomeruli 
between the four groups was 355.44 µm.  
 
The glomerular radius showed a trend (p=0.06), but was not statistically different for the four 
treatment groups (Figure 4.20D). However, statistical difference was seen between the 
C/ART+ group and the C/ART- (p=0.04), C/M+ (p=0.03) and ART+/M+ (p=0.02) groups. The 
C/ART+ group had the smallest radius of 37.62 µm and the ART+/M+ group the largest of 
41.28 µm.  
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4.4.2.3 Proximal convoluted tubules 
 
The area, diameter, perimeter, radius and thickness of three PCT’s adjacent to the measured 
renal corpuscle was measured in all animals. Only PCT’s which were cut cross-sectionally 
were selected to enable an accurate depiction of the tubule thickness and luminal properties. 
The PCT area with the lumen (LPCT) minus the luminal area was used to calculate the PCT 
area (Table 4.6). 
 
Table 4-6 Summary of the measurements of the LPCT and the PCT of the four treatment 
groups ± SD 
Treatment LPCT Area  
(µm2) 
Diameter 
(µm) 
Perimeter  
(µm) 
Radius  
(µm) 
Proximal convoluted tubules  
C/ART- 2199.64 ±705.79a 52.28 ± 8.25a 173.75 ± 29.09a 26.14 ± 4.12a 
C/ART+ 1790.34 ± 528.78b 47.28 ± 6.62b 157.86 ± 23.39b 23.64 ± 3.31b 
C/M+ 1944.93 ± 578.00ab 49.29 ± 6.82ab 162.90 ± 23.79ab 24.65 ± 3.41ab 
ART+/M+ 1998.76 ± 823.41ab 49.61 ± 8.74ab 165.28 ± 29.82ab 25.32 ± 8.58ab 
Mean 1983.52 ± 684.55 49.62 ± 7.86 164.95 ± 27.29 24.94 ± 5.40 
Proximal convoluted tubule area minus lumen 
 Area (µm2)    
C/ART- 1769.15 ± 578.80a 
   
C/ART+ 1485.03 ± 450.80b    
C/M+ 1548.56 ± 518.99b    
ART+/M+ 1614.71 ± 638.80ab    
Mean 1604.44 ± 561.12    
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
The LPCT area (Figure 4.21A) differed significantly (p=0.04) between the four groups. Post 
hoc analysis showed that the C/ART- group and C/ART+ groups’ LPCT area differed highly 
significantly (p=0.01). The C/ART- group had a PCT area of 2199.64 µm2 and the C/ART+ 
group a PCT area of 1790.34 µm2. 
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The diameter of the total PCT and its lumen differed significantly (p=0.04) between the four 
groups (Figure 4.21B). Specifically, the C/ART- and C/ART+ groups had highly significant 
differences (p<0.01) between them with diameters of 52.28 µm and 47.28 µm, respectively.  
 
 
Figure 4.21 The area, diameter, perimeter and radius of the renal corpuscle differed 
significantly between the four treatment groups. Statistical significance (p < 0.05) is indicated by 
different letters of the alphabet. If the same letter/s is/are present above each of the groups, there were no 
significant differences. 
 
The PCT’s of the C/ART- group had the largest perimeter at 173.75 µm, whereas the C/ART+ 
group had the lowest at 157.86 µm (Figure 4.21C). The perimeter of the PCT’s of the four 
treatment groups differed significantly (p=0.04). Post hoc analysis showed the C/ART- and 
C/ART+ groups had highly significant differences (p=0.01) in the perimeter of their PCT’s.  
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The radius of the PCT’s showed a trend (p=0.06) between the four treatment groups (Figure 
4.21D). Highly significant difference (p=0.01) was observed in the radius between the C/ART- 
and C/ART+ groups with 26.14 µm and 23.64 µm respectively.  
 
The area of the PCT was measured by subtracting the LPCT area with the luminal area. The 
four treatment groups showed statistical difference (p=0.04) between them with the C/ART- 
group being the largest at 1769.15 µm2 and the C/ART+ group the smallest at 1485.03 µm2 
(Figure 4.22).  
 
 
Figure 4.22 Proximal tubule area differed significantly between the four treatment 
groups. Statistical significance (p < 0.05) is indicated by different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
Highly significant difference (p<0.01) was seen between the C/ART- and C/ART+ groups. The 
C/ART- and C/M+ groups also had significant difference (p=0.03) in the PCT area.  
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4.4.2.4 Renal space 
 
The renal space (Table 4.7) was calculated by subtracting the glomerular area from the 
corpuscle area.  
Table 4-7 Summary of the measurements of the renal space of the four treatment groups 
± SD 
Treatment Area (µm2) 
Renal space  
C/ART- 3869.60 ± 1463.54a 
C/ART+ 3001.81 ± 1408.68b 
C/M+ 2720.29 ± 1175.45b 
ART+/M+ 2889.71 ± 1525.16b 
Mean 3120.35 ± 1463.54 
Statistical significance (p < 0.05) is indicated by a bold font and different letters of the alphabet. If the same letter/s 
is/are present above each of the groups, there were no significant differences. 
 
Highly significant (p<0.01) difference was seen in the renal space between the four treatment 
groups (Figure 4.23).  
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Figure 4.23 The renal space differed significantly between the four treatment groups.  
Statistical significance (p < 0.05) is indicated by different letters of the alphabet. If the same letter/s is/are present 
above each of the groups, there were no significant differences. 
 
The renal space of the C/ART- group differed highly significantly with the C/ART+ (p<0.01), 
C/M+ (p<0.01) and ART+/M+ (p<0.01) groups (Figure 4.23). The C/ART- group had the 
largest renal space of 3120.35 µm2. The C/M+ group had the lowest renal space of 2720.29 
µm2, followed by the ART+/M+ group of 2889.71 µm2. 
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CHAPTER 5 DISCUSSION 
 
The body mass of rats differs greatly between rats of different strains and stock, but they usually 
weigh between 500 g and 600 g (Hofstetter et al., 2006). In the present study, the body mass 
of each rat (8 weeks old) was between 180 g and 200 g when treatment was initiated. After 8 
weeks of treatment, the mean body mass of all the rats were 297.2 g, with no significant 
differences between the four treatment groups. Shikuma et al. (2004) found that HIV positive 
patients on HAART with very low cluster of differentiation (CD) 4 immune cell counts, and 
thus higher immune compromise, had a larger increase in body weight than patients who have 
been previously exposed to HAART and thus have a higher CD4 count. It was concluded that 
an increase in body mass is higher in patients with a higher virological count and 
immunological compromise. Furthermore, a significant increase in weight was only observed 
after 16 weeks of HAART (Shikuma et al., 2004). In the present study, the treatment was 
administered for eight weeks and no known immune compromise was present due to the HIV 
negative rat model, thus weight gain was not significant with administration of TDF/EFV/FTC.  
 
The melatonin group had the highest body mass in the present study, although melatonin has 
shown to decrease body mass in obese rats or rats on a high fat diet (HFD) (Wolden-Hanson et 
al., 2000; Puchalski et al., 2003; Hussein et al., 2007). This decrease is accompanied by a 
decrease in plasma insulin levels, triglycerides and glucose (Wolden-Hanson et al., 2000; Ríos-
Lugo et al., 2010). In the absence of a HFD in the present study, no significant increase in body 
mass or β-cell area were observed in the present study.  
 
The pancreatic islets were successfully labelled with monoclonal anti-insulin and polyclonal 
anti-glucagon, respectively. The cells in the islets positive for glucagon (α-cells) labelled brown 
and the cells positive for insulin (β-cells) red. As seen in Migrenne (2011) and Kierszenbaum 
(2013), the cells positive for insulin and the cells positive for glucagon, in the present study, 
were observed in the core and mantle, respectively. In addition, the β-cell area was significantly 
larger than the α-cell area in all of the treatment groups, as described by King et al. (2007) and 
Kierszenbaum (2013) as the standard relationship of β-cell and α-cell area ratio.  
 
Rat pancreatic islets are composed of 60-85% β-cells and 15-25% α-cells as originally 
described by Erlandsen et al. (1976) and Wieczorek et al. (1998). In the present study, the β-
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cells comprised 33-36% of the pancreatic islets, with no significant differences between the 
four treatment groups. Similarly, the α-cells in the present study comprised 6-7% of the total 
pancreatic islet area, with no significant differences between the four treatment groups. The 
duodenal region of the rat pancreas has been described to be glucagon-poor, as opposed to the 
splenic region (Baetens et al., 1979; Dolensek et al., 2015). In the present study, the pancreatic 
islets of the duodenal lobe of the pancreas were analysed, which may explain the smaller 
percentages of glucagon and insulin expression in the islets. Furthermore, King et al. (2007) 
showed that β-cells are not dependant on non-β-cells for optimal functioning as seen in islet 
transplantation of mice.  
 
It has been well-described that pancreatic islets of various mammals, including rats and 
humans, express melatonin trans-membrane receptors MT1 and MT2 (Peschke et al., 2007; 
Ramracheya et al., 2008; Bähr et al., 2012; Peschke et al., 2013). According to Bähr et al. 
(2011), melatonin stimulates glucagon secretion in vivo and in vitro in Wistar rats by inhibiting 
insulin secretion and stimulating glucagon synthesis (Farhadi et al., 2015). In the present study, 
the α-cell area was significantly higher in the melatonin group compared to the group subjected 
to cART, which indicates that melatonin stimulated glucagon expression in the pancreatic 
islets. 
 
No significant difference in insulin expression was seen between the four treatment groups. 
The latter contradicts studies done by la Fleur et al. (2001), Peschke et al., (2006) and Peschke 
et al. (2007), which indicates that melatonin inhibits insulin secretion. However, in the present 
study, the number of pancreatic islets per mm2 were significantly more in the melatonin group 
than in both the control and the experimental groups. The groups affected suggest that 
melatonin treatment stimulates a higher number of pancreatic islets, whereas cART has no 
significant effect on the number of pancreatic islets. It is possible that melatonin stimulates 
pancreatic islet production and thus the ability to secrete glucagon and insulin, but not 
necessarily the hormones themselves. 
 
Blümer et al. (2008) and van Vonderen et al. (2010) concluded that NRTIs affect glucose 
metabolism and induce insulin resistance humans, which in turn will increase insulin levels in 
the body. In the present study, no significant differences were seen in groups subjected to cART 
in neither glucagon nor insulin expression. This may be due to the treatment only being 
administered for eight weeks, which is equivalent to approximately 5-6 years for humans 
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(Adami Andreollo et al., 2012). The specific combination of TDF/EFV/FTC may not induce 
insulin resistance and alteration in glucose metabolism in patients as early (within three 
months) or aggressively as zidovudine and lamivudine (Blümer et al., 2008; Paik and Kotler, 
2011). 
 
No histopathology was observed in the pancreas of any of the four treatment groups, which is 
contradicting to studies conducted by Muñoz-Casares et al. (2006), Barbosa et al. (2013) and 
Oliveira et al. (2014). Barbosa et al. (2013) describes pancreatitis, steatosis and apoptosis in 
the pancreas of HIV positive patients on cART. In the present study, no lymphocyte infiltration, 
oedema, necrosis, haemorrhage, apoptosis or necrosis were observed in the exocrine part of the 
pancreata, which showed that the TDF/EFV/FTC combination did not induce pancreatitis or 
cellular injury after 8 weeks of treatment in rats. 
 
Various authors have commented on the protective effects of melatonin on the exocrine and 
endocrine pancreas (Baydas et al., 2002; Picinato et al., 2002b; Muñoz-Casares et al., 2006; 
Radogna et al., 2010). These studies describe the action of melatonin during oxidative stress, 
necrosis, acute pancreatitis and inflammatory conditions. In the present study, the ameliorating 
effects of melatonin could not be observed as cART did not induce any histologically 
observable changes on tissue level. 
 
Most of the changes in histopathology were reversible (Haschek et al., 2009a; Cha et al., 2016) 
or may have been incidental findings due to fixation, however, it was included for complete 
disclosure of the findings. Formaldehyde derivatives such as 4% PFA has proven to be effective 
in preserving tissue for histological examination (Hassel and Hand, 1974). As all samples were 
collected simultaneously in the present study, a fixative which is appropriate for multiple 
organs and purposes (H&E, special staining and IHC) had to be used for all organs.  
 
All tissue samples were immediately immerged in 4% PFA after the specific rat was 
euthanised. Although extreme care was taken to ensure that proper fixation took place, some 
control animals showed histopathology, which might indicate that autolysis took place. 
Multiple researchers were collecting tissue from each rat in order to reduce the number of 
animals sacrificed for research purposes as stated by the three R’s of animal ethics (Prescott 
and Lidster, 2017). This caused suboptimal waiting periods for tissue collection. However, all 
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samples were treated consistently, and thus statistically significant changes observed are most 
likely treatment dependant or incidental.  
 
In the present study, proteinaceous material was seen in the pancreatic ducts, which was noted 
to be normal pancreatic enzymes produced by the zymogen granules of the acinar cells 
(Kierszenbaum, 2007). Some pancreata had included lymph tissue, which appeared mildly and 
moderately active, respectively. These observations were in the cART, melatonin and 
experimental groups, with no statistical significance between the groups. As lymph nodes are 
sensitive to both endogenous and exogenous factors, the cause of the activity is hard to 
determine (Ibraheem et al., 2013). In addition, no inflammatory cells or necrosis was observed, 
neither did the lymph tissue penetrate the parenchyma and thus it is likely that the lymph tissue 
activity observed in the present study is incidental and due to exogenous factors (Ibraheem et 
al., 2013). 
 
In the livers observed in the present study, very mild hepatocyte changes were seen, although 
none of the observations were significant. Mild granular appearance and vacuolation of the 
hepatocytes were seen in all treatment groups, but were most prevalent in the control group, 
which indicates that autolysis may have been initiated. As vacuolation of hepatocytes causes a 
granular appearance of the tissue (Haschek et al., 2009a), the granular appearance observed in 
the present study may be due to artefactual vacuolation.  Additionally, one rat in the melatonin 
group showed mild lymphocyte infiltration around the portal areas, which may be incidental 
as it was only observed in one animal.  
 
The findings in the present study does not correspond with hepatic steatosis, cellular injury, 
nodular hyperplasia, fibrosis and hepatitis as described by Sulkowski (2004), Chang and 
Schiano (2007), Núñez (2010), Neuman et al. (2013) and Gallien et al. (2015) in HIV positive 
patients receiving cART. It is possible that the immune compromise of HIV enhances possible 
side effects or histopathology as it allows for opportunistic infections to manifest (Kim and 
Rutstein, 2010). Similar to the pancreas, melatonin had no effect on the histology of the liver 
as there was no histologically significant changes induced by cART. 
 
Furthermore, liver enzyme tests were done to determine the hepatocellular integrity of the liver. 
Elevated AST and ALT serum levels indicate membrane permeability, cellular degeneration or 
cellular necrosis, which is indicative of hepatotoxicity (Haschek, et al., 2009b). No significant 
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differences were seen in serum AST or ALT levels between the four treatment groups. The 
normal AST value in male Sprague Dawley rats range between 74-143 U/L and the normal 
ALT value range between 18-45 U/L (Giknis and Clifford, 2008).  In the present study, the 
AST and ALT values ranged between 161-218 U/L and 54-68 U/L, respectively. The values in 
the present study are higher than reported as the standard, but similar to a study conducted by 
Alarifi et al. (2012), who measured AST and ALT values of 143-224 U/L and 34-61 U/L, 
respectively, in control albino Wistar rats.  
 
Mild significant elevations (1-3 times the normal) in AST and ALT may indicate, non-alcoholic 
steatohepatitis (NASH), drug toxicity or myositis in humans (Thapa and Walia, 2007). 
However, these conditions are highly unlikely to be the cause of elevated liver enzyme levels 
in the present study, due to the insignificant differences in AST and ALT between the treatment 
groups. According to Haschek et al.  (2009), female B6C3F1 mice which received oral gavage 
had a significantly higher ALT value than mice that were not gavaged. In the present study, the 
rats received oral gavage, which may have caused an increase in liver enzyme values. The 
normal AST and ALT values indicate that no significant hypoxia, fatty change, necrosis or 
liver injury were induced by cART treatment or melatonin supplementation.  
 
Similarly, no significant difference was seen in the AST/ALT ratio between the four treatment 
groups. However, the ratio of AST/ALT was higher than 1 in all treatment groups, which 
indicates chronic liver disease (CLD) observed as cirrhosis and fibrosis on tissue level (Parise 
et al., 2006; Thapa and Walia, 2007; Nsiah et al., 2011). Furthermore, a decrease in ALT 
specifically may indicate pyridoxine deficiency (Thapa and Walia, 2007). In the present study, 
the high ratio of approximately 3 is most likely due to the above average values of both AST 
and ALT. Liver injury is also highly unlikely in the present study, as no fibrosis or cirrhosis 
was observed with the histopathology analysis. Bilirubin, haemoglobin and lipaemia tests were 
conducted to determine interferences in the sample values of AST and ALT (Glick et al., 1986; 
Thapa and Walia, 2007). 
 
In the present study, the mean haemoglobin value of the control group was 50.9 g/dl, which is 
much higher than the reported range of 13.7-17.6 g/dl for laboratory rats under anaesthesia 
(Car et al., 2006; Giknis and Clifford, 2008). Increased haemoglobin in the blood may be 
indicative of haemolysis of the red blood cells (RBCs). This rupturing of RBCs elevates AST, 
ALT and bilirubin values of liver enzyme tests (Car et al., 2006). Bilirubin values should be 
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between 0.10 mg/dl and 0.21 mg/ dl in rats under anaesthesia (Car et al., 2006; Giknis and 
Clifford, 2008). In the present study, all samples with significant haemolysis was discarded, 
although the abnormally high haemoglobin values in all four treatment groups, may still have 
affected the AST and ALT values reported. This is, however, unlikely due to the bilirubin 
values, which was < 0.21 mg/dl in all the blood samples in the present study.  
 
Patients with HIV have significantly lower haemoglobin values as the disease progresses, 
which could lead to anaemia (Obirikorang and Yeboah, 2009). In the present study, the group 
which was subjected to cART had a significantly higher haemoglobin value than the control 
group. This indicates that cART may not only restore haemoglobin levels in anaemic HIV 
positive patients (Johannessen et al., 2011; Kibaru et al., 2015), but also increases haemoglobin 
in the absence of HIV in a rat model. Although no significant difference was observed in the 
haemoglobin values of the melatonin group compared to the control group in the present study, 
previous research has indicated that melatonin increases haemoglobin levels in animals and 
humans (Hlutkin and Zinchuk, 2008; Ahmed and Salem, 2011). As melatonin may be 
transported through the blood by binding to haemoglobin, a decrease in haemoglobin may thus 
affect the antioxidant and hormone action of melatonin (Gilad and Zisapel, 1995). 
 
Melatonin has shown to inhibit lipid peroxidation in the liver, by binding the free radicals that 
cause this lipid degradation (Sigala et al., 2006). Lipaemia can be expressed as the 
accumulation of triglycerides and lipoprotein particles such as chylomicrons and very low 
density lipoprotein (VLDL), LDL and HDL in the blood (Rudel et al., 1990; Nikolac, 2014).  
Several ARTs such as EFV and nevirapine have shown to increase various lipid parameters 
such as lipoprotein size and abundance in HIV positive patients. Although EFV has shown to 
increase hypercholesterolemia in HIV positive patients, (Fisher et al., 2006; Olivero-David et 
al., 2011) the present study showed no significant differences in the lipaemia index of the cART 
group.  
 
In the present study, the melatonin group had a significant decrease in serum lipids compared 
to the control, which correlates with studies conducted by Sener et al. (2002a) and Sener et al. 
(2002b). The fore-mentioned studies in rats highlighted that melatonin scavenges free radicals 
generated by renal ischemia and nephrotoxicity before these radicals can degrade lipids from 
cell membranes (Mylonas and Kouretas, 1999; Sener et al., 2002a; Sener et al., 2002b).  
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Adjene, et al. (2011) found that chronic EFV administration in rats decreased kidney weight, 
which may have been caused by non-pathological cellular distortion or disruption or 
intracellular swelling. Furthermore, Adjene, et al. (2011) postulates that these changes are due 
to the cytotoxic effect or EFV. In the present study, the area, diameter, perimeter and radius of 
the renal corpuscles were significantly lower in both the cART and melatonin groups compared 
to the control group. Although EFV has shown to induce apoptosis (Eweka, 2009; Adjene et 
al., 2011) and melatonin has been reported to modulate the immune system by inducing 
apoptosis (Hara et al., 2013), no changes in histopathology were observed in the present study.  
 
In the present study, the area, diameter and radius of the glomeruli was significantly lower in 
the cART group compared to the other three groups. Tenofovir DF may cause a decrease in 
eGFR due to its effects on tubular function in the absence and presence of altered glomerular 
structure (Post et al., 2010; Squillace et al., 2017). The decrease of glomerular size, in the 
cART group can be due to damaged podocytes as seen in herbicide poisoning in mice (Gu et 
al., 2016). It is thus postulated that the eGFR may have been decreased in rats treated with 
TDF/EFV/FTC due to the compromise of glomerular structure together with possible altered 
tubular function in the present study.  
 
The renal space was significantly lower in the cART, melatonin and experimental groups 
compared to the control. A smaller renal space can either be due to a decrease in the renal 
corpuscle area or an increase in the glomerular area. In the present study, both the renal 
corpuscle and glomerular parameters were smaller than the cART groups. It is possible that the 
cellular disruption of the renal corpuscles in this study were more significant than the cellular 
disruption of the glomeruli, which lead to the decrease in the renal space. This finding differs 
from Adjene et al. (2011) who found that a dilated renal space is associated with EFV-
associated glomerulonephritis in rats. The results in the present study varies from Bellés et al. 
(2007), who reported a normal appearance of glomeruli in rats exposed to uranium-induced 
nephrotoxicity and melatonin. However, the study conducted by Bellés et al. (2007) did not 
conduct morphometric measurements, but evaluated the glomeruli using a semi-quantitative 
method. It is thus possible that changes in glomerular size as observed in the present study, 
using morphometric measurements, may have been overlooked by Bellés et al. (2007). 
 
In the present study, the LPCT area (PCT area plus lumen), diameter, perimeter and radius of 
the PCTs was significantly lower in the cART group compared to the control. Degeneration of 
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tubular cells is a characteristic of nephrotoxicity induced by cART (Jao and Wyatt, 2010; 
Achhra et al., 2016). Thus, the smaller PCT parameters is indicative of the early stages of 
nephrotoxicity in the cART group, whereas no possible degradation of the PCT parameters 
were seen in the groups exposed to melatonin. Lipid peroxidation and protein oxidation, which 
leads to nephrotoxicity, may be restored by the cytoprotective role of melatonin in the kidneys 
(Hara et al., 2001; Sener et al., 2002b).  
 
The area of the PCT minus lumen (PCT) was significantly lower in the cART and melatonin 
groups in the present study compared to the control. This is suggestive of a larger lumen, which 
may have been caused by luminal ectasia (dilation of a tubular structure) as seen in Labarga et 
al. (2009) and Jao and Wyatt (2010) with the administration of TDF in rats. As TDF is secreted 
into the PCTs, it may cause cellular injury which can lead to nephrotoxicity (Jao and Wyatt, 
2010). It is also possible that the larger luminal area was seen due to a loss in the brush border 
of the PCTs, which would severely affect the reabsorption of essential molecules in the body 
(Haschek et al., 2009c; Jao and Wyatt, 2010). Although TDF has been shown to affect the 
tubular function in the kidneys or rats, Post et al. (2010) postulates that TDF does not cause 
tubular injury per se. This correlates with the findings in the present study, where no observable 
histopathology was seen, but a significant difference in various parameters of the nephron was 
measured. As discussed above, melatonin may induce apoptosis and necrosis in unfavourable 
conditions (Muñoz-Casares et al., 2006; Diger Hardeland et al., 2010). However, no necrosis 
or apoptosis were observed with evaluation of histopathology and it is unclear whether 
melatonin had a protective role in restoring morphometric parameters as seen in cART 
administration due to cART, which did not induce such changes.  
 
Hydropic changes expressed swelling and vacuolation were observed in the kidneys of all 
treatment groups, with no significant differences in the present study. However, the prevalence 
of vacuolation of the PCTs in the melatonin and experimental groups in comparison with the 
control and cART groups showed a trend. The two groups that were exposed to melatonin both 
had 70% of vacuolation, compared to 38% in the control and 30% in the cART group. Hara et 
al. (2013) found that the mechanism by which melatonin modulates the immune system in 
humans can induce apoptosis of colostrum mononuclear cells. As hydropic changes are one of 
the first changes observed after cellular injury on tissue level, vacuolation observed in the 
present study may be indicative of the early stages of apoptosis. These changes are, however, 
still reversible (Haschek, et al., 2009a). In addition, no fibrosis, degenerative changes of tubular 
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epithelial cells or glomerulonephritis were observed in the cART group as described by Van 
Rompay et al. (2004) and Adjene et al. (2011) in rhesus monkeys and rats, respectively.  
 
As mentioned with the pancreas and liver, the treatment duration of TDF/EFV/FTC may not 
cause histologically observable histopathological changes in eight weeks in Wistar rats. 
Melatonin may be more effective in HIV positive patients receiving cART, as the compounding 
effects may induce histologically observable changes. However, the focus of this study was to 
observe changes in an HIV negative model to distinguish between the symptoms of HIV and 
the side effects of the specific combination of TDF/EFV/FTC on tissue level. 
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CHAPTER 6 CONCLUSION 
 
6.1 CONCLUDING REMARKS  
 
This project aimed to address the lack of research regarding the histomorphometric changes of 
cART in the pancreas, liver and kidney. It also aimed to evaluate melatonin as a possible 
therapeutic option to eradicate these side effects. 
 
In the present study, significant morphometric changes caused by cART were seen in all 
components of the nephron. Administration of TDF/EFV/FTC for 8 weeks in a rat model 
decreased the parameters of the renal corpuscle, glomerulus, renal space and PCTs, possibly 
due to the cytotoxic effects and decrease in tubular function induced by cART. Melatonin 
decreased renal corpuscle parameters, the renal space and the PCT area. It is possible that 
melatonin induced apoptosis and necrosis in these structures to prevent further tissue damage 
induced by possible inflammation. It is also possible that excess melatonin levels in the body 
may cause negative changes in the kidney’s histomorphology due to difficulty in excretion or 
reabsorption of this molecule.   
 
Haemoglobin and lipaemia values were affected by cART and melatonin, respectively. 
Administration of cART restores the anaemic haemoglobin values in HIV positive patients and 
thus the results show that the mechanism in which cART elevates serum haemoglobin is still 
active in the absence of anaemia or immunodeficiency. Melatonin decreased serum lipids in 
the present study, due to its inhibitory effect on peroxidation of cellular lipids by free radicals.  
 
This study concluded that melatonin at the dose of 0.01 mg/g/day and 25.8 mg/kg/day TDF, 
51.6 mg/kg/day EFV and 17.4 mg/kg/day FTC will exert a histologically observable effect on 
the kidneys in a Wistar rat model in the absence of HIV.  Care must be taken in prescribing 
melatonin or TDF/FTC/EFV in HIV positive patients with renal damage or the susceptibility 
thereof.  
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6.2 LIMITATIONS OF THE STUDY AND PROSPECTIVE RESEARCH 
 
The experiment was designed to reduce the number of rats sacrificed as much as possible and 
thus multiple researchers utilised the tissue from each rat. This caused suboptimal harvesting 
time in some cases and autolysis may have occurred in some samples. This also caused that 
three blood samples had to be excluded from analyses of liver enzymes due to insufficient 
blood collection.  
 
Prospective research may include the measurement of free radicals in the same rat model to 
determine whether the changes in morphometry that melatonin induced in the kidney was 
restorative. Urea of the rats can also be monitored and tested daily to determine kidney function 
in the same rat model. The expression of melatonin receptors in β-cells (M1 and M2) can also 
be observed in different doses and conditions. Lastly, blood parameters such as growth 
hormone can also be evaluated to observe the physiological effects of melatonin on the normal 
hormone homeostasis in the body.  
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APPENDIX 1 Haematoxylin and eosin protocol 
 
The staining was done using an automated stainer (Leica Auto Stainer XL; Manufacturer & 
Model: Leica St 5010; Serial Number 1732/07.2007). 
 
Procedure:  
1. Dewax sections through xylene and alcohol. 
2. Stain in Haematoxylin for 4 minutes.  
3. Wash in running tap water for 3 minutes.  
4. Stain in Eosin for 2.30 seconds.  
5. Wash in running tap water for 2 minutes.  
6. Dehydrate and mount with DPX mounting medium. 
 
Results:  
Nuclei------------------------------------------------------------------- Blue  
Cytoplasm-------------------------------------------------------------- Pink  
Red blood cells, eosinophilic granules, other tissue elements--- Varying shades of pink  
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APPENDIX 2 Immunolabeling for anti-glucagon and anti-insulin protocol 
 
Medical Research Council of South Africa SOP No:  ICC\B7-V01 
 
Reagents: 
 
• Distilled Water 
• Hydrogen Peroxide 
• 0.05M Tris Buffered Saline (TBS) pH7.2 
• 0.1M Phosphate Buffered Saline (PBS) pH7.2 
• Normal Goat Serum 
• Normal Horse Serum 
• Polyclonal Anti-Glucagon (Doka, North America) 
• Monoclonal Anti-Insulin (Doka, North America) 
• Biotinylated Rabbit Anti-IgG  
• Biotinylated Mouse Anti-IgG 
• Vectastain (Doka, North America) 
• EnvisionG/2 System/AP Kit 
• Liquid DAB+ Substrate Chromagen Solution (Doka, North America) 
• Haematoxylin 
 
Procedure: 
1. Dewax sections through xylene and alcohol. 
2. Rinse slides in staining jar in distilled water. 
3. Block for endogenous peroxidase with 3% hydrogen peroxide (H2O2) for five (5) 
minutes in staining jar. (6ml H2O2/194ml distilled water – left fridge). 
4. Rinse slides with 0.05M TBS pH7.2 for five (5) minutes in staining jar.  
5. Dry around section and add normal goat serum (NGS) 1:20 to slides in a moisture 
chamber (completely cover the section) for twenty (20) minutes at room temperature 
(18°C- 20°C). 
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6. Blot excess serum. (Do not rinse). 
7. Add approximately 100µl anti-glucagon (P) (primary antibody) 1:100 to sections in 
moisture chamber and incubate at room temperature (18°C- 20°C) for thirty (30) 
minutes.  
8. Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for five 
(5) minutes. (N.B. Make up Biotinylated Anti-Rabbit IgG and Vectastain). 
9. Dry around sections and add Biotinylated Anti-Rabbit IgG 1:200 to slides in moisture 
chamber for (30) minutes at room temperature (18°C- 20°C). 
10. Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for ten 
(10) minutes. 
11. Dry around sections and add Vectastain to slides in moisture chamber for one (1) hour 
at room temperature (18°C- 20°C). 
12. Jet wash slides with 0.05M TBS pH 7.2 and rinse for ten (10) minutes in 0.05M TBS 
pH7.2 in staining jar. 
13. Dry around sections and add Liquid DAB+ Chromagen solution to slides on a rack over 
the sink for five (5) minutes. (Check progress under microscope). 
14. Jet wash slides with distilled water and rinse with distilled water in a staining jar for 
five (5) minutes. 
15. Rinse slides in 0.05M TBS pH7.2 in staining jar for five (5) minutes. 
16. Dry around section and add normal horse serum (NHS) 1:20 to slides in a moisture 
chamber 
17. (completely cover the section) for twenty (20) minutes at room temperature (R.T.) 
(18°C- 20°C).  
18. Blot excess serum. (Do not rinse). 
19. Add approximately 100µl anti-insulin (M) 1:10 000 to sections in moisture chamber 
and incubate at 4ºC overnight. 
20. Allow slides to reach room temperature. 
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21. Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for five 
(5) minutes.  
22. Dry around sections and add 100µl Rabbit/Mouse (LINK) to slides in moisture chamber 
for thirty (30) minutes at room temperature (R.T.) (18°C- 20°C). 
23. Jet wash with 0.05M TBS pH7.2 and rinse in staining jar in 0.05M TBS pH7.2 for ten 
(10) minutes. 
24. Dry around sections and add 100ul AP Enzyme (ENHANCER) to slides in moisture 
chamber thirty (30) minutes at  room temperature  (R.T.) (18°C- 20°C).  
25. Jet wash slides with 0.05M TBS pH 7.2 and rinse for ten (10) minutes in 0.05M TBS  
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APPENDIX 3 Periodic acid Schiff protocol 
 
Solutions and Reagents: 
 
0.5% Periodic Acid Solution: 
 
Periodic acid-----------0.5g 
Distilled water---------100ml 
 
Schiff’s reagent: 
 
Schiff’s reagent with pararosaline  
 
Procedure: 
 
1. Deparaffinize and hydrate to water. 
2. Treat with periodic acid for 5 minutes. 
3. Rinse well in distilled water. 
4. Cover with Schiff’s reagent for 15 minutes. 
5. Wash in running lukewarm tap water for 5 minutes. 
6. Counter stain with Mayer’s haematoxylin for 1 minute. 
7. Wash in tap water for 5 minutes. 
8. Dehydrate and mount with DPX mounting medium. 
 
Results: 
 
Glycogen, mucin and some basement membranes--------red/purple 
Fungi-------------------------------------------------------------red/purple 
Background------------------------------------------------------blue 
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APPENDIX 4 Liver enzyme tests 
 
Analyzer:  Roche/Hitachi cobas c 311, cobas c 501/502 
 
Table A Materials needed for AST and ALT tests 
20764957 322 Alanine Aminotransferase acc. to 
IFCC 500 tests 
System‑ID 07 6495 7 
20764949 322 Aspartate Aminotransferase acc. to 
IFCC 500 tests 
System‑ID 07 6494 9 
10759350 190 Calibrator f.a.s. (12 x 3 mL)  Code 401 
10759350 360 Calibrator f.a.s. (12 x 3 mL, for USA)  Code 401 
12149435 122 Precinorm U plus (10 x 3 mL)  Code 300 
12149435 160 Precinorm U plus (10 x 3 mL, for 
USA)  
Code 300 
12149443 122 Precipath U plus (10 x 3 mL)  Code 301 
12149443 160 Precipath U plus (10 x 3 mL, for USA)  Code 301 
10171743 122 Precinorm U (20 x 5 mL)  Code 300 
10171778 122 Precipath U (20 x 5 mL) Code 301 
10171760 122 Precipath U (4 x 5 mL)  Code 301 
05117003 190 PreciControl ClinChem Multi 1 (20 x 5 
mL) 
Code 391 
05947626 190 PreciControl ClinChem Multi 1 (4 x 5 
mL) 
Code 391 
05947626 160 PreciControl ClinChem Multi 1 (4 x 5 
mL, for USA) 
Code 391 
05117216 190 PreciControl ClinChem Multi 2 (20 x 5 
mL)  
Code 392 
05947774 190 PreciControl ClinChem Multi 2 (4 x 5 
mL) 
Code 392 
05947774 160 PreciControl ClinChem Multi 2 (4 x 5 
mL, for USA) 
Code 392 
04489357 190 Diluent NaCl 9 % (50 mL) System‑ID 07 6869 3 
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Aspartate Aminotransferase (AST) 
 
Reagents:  
1. TRIS buffer: 264 mmol/L, pH 7.8 (37 °C); L‑aspartate: 792 mmol/L; MDH 
(microorganism):  24 μkat/L; LDH (microorganisms): ≥ 48 μkat/L; albumin (bovine): 
0.25 %; preservative 
2. NADH: ≥ 1.7 mmol/L; 2‑oxoglutarate: 94 mmol/L; preservative 
 
Assay: 
 
Assay type---------------------------------------------------------- Rate A 
Reaction time / Assay points------------------------------------ 10 / 12‑31 
Wavelength (sub/main) ------------------------------------------ 700/340 nm 
Reaction direction------------------------------------------------- Decrease 
Units ---------------------------------------------------------------- U/L (μkat/L) 
Reagent pipetting-------------------------------------------------- Diluent (H2O) 
Reagent 1------------------------------------------------------------51 μL 
Reagent 2------------------------------------------------------------20 μL 
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Alanine Aminotransferase (ALT) 
 
Reagents: 
 
1. TRIS buffer: 224 mmol/L, pH 7.3 (37 °C); L‑alanine: 1120 mmol/L; albumin 
(bovine): 0.25 %; LDH (microorganisms): ≥ 45 μkat/L; stabilizers; preservative 
2. 2‑Oxoglutarate: 94 mmol/L; NADH: ≥ 1.7 mmol/L; additives; preservative 
 
Assay: 
 
Assay type---------------------------------------------------------- Rate A 
Reaction time / Assay points------------------------------------ 10 / 12‑31 
Wavelength (sub/main) ------------------------------------------ 700/340 nm 
Reaction direction------------------------------------------------- Decrease 
Units ---------------------------------------------------------------- U/L (μkat/L) 
Reagent pipetting---------------------------------------------------Diluent (H2O) 
Reagent1-------------------------------------------------------------32 μL 
Reagent 2------------------------------------------------------------20 μL 
  
Stellenbosch University  https://scholar.sun.ac.za
109 
 
APPENDIX 5 p-values obtained from pancreas measurements 
 
P-values for Table 4.1: Summary of the measurements on the pancreatic islets in the 
pancreas labelled with anti-insulin and anti-glucagon ± SD of the four treatment groups. 
 
Cel
l 
No
. 
LSD test; variable Total Islet area (Breakdown Table of Descriptive Statistics 
(Spreadsheet in Corrected islet area.stw) in Corrected islet area.stw) Probabilities for 
Post Hoc Tests Error: Between MS = 2496E3, df = 36.000 
Treatment 
 
{1} 
4755.7 
 
{2} 
4113.9 
 
{3} 
4928.8 
 
{4} 
5249.8 
 
1 
 
C/ART-  0.369736 0.807860 0.488799 
2 
 
ART 0.369736  0.256375 0.116628 
3 
 
ART+/M+ 0.807860 0.256375  0.652261 
4 
 
C/M+ 0.488799 0.116628 0.652261  
 
P-values for Figure 0.1: The area of the α- and β-cells did not differ between the four 
treatment groups. 
 
Cel
l 
No
. 
LSD test; variable A cell area (Breakdown Table of Descriptive Statistics (Spreadsheet in 
Corrected islet area.stw) in Corrected islet area.stw) Probabilities for Post Hoc Tests 
Error: Between MS = 48882., df = 36.000 
Treatment 
 
{1} 
443.58 
 
{2} 
352.71 
 
{3} 
442.87 
 
{4} 
582.72 
 
1 
 
C/ART-  0.364205 0.994338 0.167934 
2 
 
ART 0.364205  0.367904 0.025751 
3 
 
ART+/M+ 0.994338 0.367904  0.165842 
4 
 
C/M+ 0.167934 0.025751 0.165842  
 
P-values for Figure 0.2: The area of the α- and β-cells did not differ between the four 
treatment groups. 
 
Cel
l 
No
. 
LSD test; variable B cell area (Breakdown Table of Descriptive Statistics (Spreadsheet in 
Corrected islet area.stw) in Corrected islet area.stw) Probabilities for Post Hoc Tests 
Error: Between MS = 7031E2, df = 36.000 
Treatment 
 
{1} 
1902.8 
 
{2} 
1468.6 
 
{3} 
1880.7 
 
{4} 
1838.7 
 
1 
 
C/ART-  0.254550 0.953459 0.865417 
2 
 
ART 0.254550  0.279031 0.330158 
3 
 
ART+/M+ 0.953459 0.279031  0.911503 
4 
 
C/M+ 0.865417 0.330158 0.911503  
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P-values for Table 0-1: Percentage of α-cell area and β-cell area in the pancreatic islets ± 
SD of the four treatment groups 
 
Cel
l 
No
. 
LSD test; variable % A cells (Breakdown Table of Descriptive Statistics (Spreadsheet in 
Corrected islet area.stw) in Corrected islet area.stw) Probabilities for Post Hoc Tests 
Error: Between MS = 6.2989, df = 36.000 
Treatment 
 
{1} 
6.6474 
 
{2} 
5.8641 
 
{3} 
6.8949 
 
{4} 
6.8567 
 
1 
 
C/ART-  0.489761 0.826722 0.853081 
2 
 
ART 0.489761  0.364550 0.382369 
3 
 
ART+/M+ 0.826722 0.364550  0.973078 
4 
 
C/M+ 0.853081 0.382369 0.973078  
 
P-values for Table 0-2: Percentage of α-cell area and β-cell area in the pancreatic islets ± 
SD of the four treatment groups 
 
Cel
l 
No
. 
LSD test; variable % B cells (Breakdown Table of Descriptive Statistics (Spreadsheet in 
Corrected islet area.stw) in Corrected islet area.stw) Probabilities for Post Hoc Tests 
Error: Between MS = 55.416, df = 36.000 
Treatment 
 
{1} 
36.070 
 
{2} 
34.905 
 
{3} 
33.213 
 
{4} 
33.609 
 
1 
 
C/ART-  0.728255 0.396346 0.464460 
2 
 
ART 0.728255  0.614382 0.699397 
3 
 
ART+/M+ 0.396346 0.614382  0.905927 
4 
 
C/M+ 0.464460 0.699397 0.905927  
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APPENDIX 6 p-values obtained from body weight and liver enzyme tests 
 
P-values for the graphs of figure 4.1: Body mass of the rats did not differ significantly 
between the four treatment groups 
 
Comparisons Cell 
{#1}-{#2} 
LSD test; variable Body weight (Body weights) Simultaneous 
confidence intervals Effect: Treatment 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95,00% 
Cnf.Lmt 
 
+95,00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 10.9351 9.33022 0.247502 -7.8688 29.73888 
{1}-{3} 
 
C/ART- C/M+ -3.7143 8.75252 0.673366 -21.3538 13.92526 
{1}-{4} 
 
C/ART- ART+/M+ 4.5714 9.89375 0.646320 -15.3681 24.51096 
{2}-{3} 
 
C/ART+ C/M+ -14.6494 9.33022 0.123557 -33.4532 4.15447 
{2}-{4} 
 
C/ART+ ART+/M+ -6.3636 10.40829 0.544081 -27.3402 14.61290 
{3}-{4} 
 
C/M+ ART+/M+ 8.2857 9.89375 0.406855 -11.6538 28.22525 
 
P-values for Table 0-3: Summary of the values from liver function tests ± SD of the four 
treatment groups 
 
Cell 
No. 
LSD test; variable Alanine transaminase (ALT) (Spreadsheet in Workbook18) 
Probabilities for Post Hoc Tests Error: Between MS = 946.30, df = 33.000 
Treatment 
 
{1} 
62.400 
 
{2} 
54.400 
 
{3} 
59.400 
 
{4} 
68.143 
 
1 
 
C/ART-  0.564846 0.828719 0.707245 
2 
 
C/ART+ 0.564846  0.718590 0.371223 
3 
 
C/M+ 0.828719 0.718590  0.568044 
4 
 
ART+/M+ 0.707245 0.371223 0.568044  
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P-values for Table 0-4: Summary of the values from liver function tests ± SD of the four 
treatment groups 
 
Cell 
No. 
LSD test; variable Aspartate transaminase (AST) (Spreadsheet in Workbook18) 
Probabilities for Post Hoc Tests Error: Between MS = 7374.8, df = 33.000 
Treatment 
 
{1} 
181.50 
 
{2} 
160.80 
 
{3} 
188.60 
 
{4} 
217.71 
 
1 
 
C/ART-  0.593512 0.854462 0.398326 
2 
 
C/ART+ 0.593512  0.474252 0.187847 
3 
 
C/M+ 0.854462 0.474252  0.496293 
4 
 
ART+/M+ 0.398326 0.187847 0.496293  
 
 
P-values for Table 0-5: Summary of the values from liver function tests ± SD of the four 
treatment groups 
 
Cell 
No. 
LSD test; variable AST/ALT Ratio (Spreadsheet in Workbook18) Probabilities for Post 
Hoc Tests Error: Between MS = .48465, df = 33.000 
Treatment 
 
{1} 
2.9212 
 
{2} 
3.0161 
 
{3} 
3.3243 
 
{4} 
3.2985 
 
1 
 
C/ART-  0.762335 0.204371 0.279335 
2 
 
C/ART+ 0.762335  0.329433 0.416314 
3 
 
C/M+ 0.204371 0.329433  0.940569 
4 
 
ART+/M+ 0.279335 0.416314 0.940569  
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P-values for Figure 0.3: Serum haemoglobin value differed significantly between the 
C/ART- group and C/ART+ group.  
 
Cell 
No. 
LSD test; variable Serum haemoglobin value (Spreadsheet in Workbook18) 
Probabilities for Post Hoc Tests Error: Between MS = 1849.0, df = 31.000 
Treatment 
 
{1} 
50.900 
 
{2} 
98.000 
 
{3} 
66.200 
 
{4} 
92.167 
 
1 
 
C/ART-  0.023435 0.432302 0.072627 
2 
 
C/ART+ 0.023435  0.117636 0.798576 
3 
 
C/M+ 0.432302 0.117636  0.251157 
4 
 
ART+/M+ 0.072627 0.798576 0.251157  
 
P-values for Figure 0.4: Serum lipaemia value differed significantly between the C/ART- 
group and C/M+ group.  
 
Cell 
No. 
LSD test; variable Serum lipaemia value (Spreadsheet in Workbook18) Probabilities 
for Post Hoc Tests Error: Between MS = 18.782, df = 31.000 
Treatment 
 
{1} 
12.000 
 
{2} 
8.3333 
 
{3} 
6.9000 
 
{4} 
9.6667 
 
1 
 
C/ART-  0.075150 0.013130 0.305189 
2 
 
C/ART+ 0.075150  0.477028 0.563616 
3 
 
C/M+ 0.013130 0.477028  0.225653 
4 
 
ART+/M+ 0.305189 0.563616 0.225653  
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APPENDIX 7 p-values obtained from kidney measurements 
 
P-values for Figure 0.5: The area, diameter, perimeter and radius of the renal corpuscle 
differed significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Area (Spreadsheet in Kidney data final.stw) Simultaneous 
confidence intervals Effect: Treatment Include condition: V4="Renal 
Corpuscle" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 1709.519 509.6210 0.001884 675.96 2743.078 
{1}-{3} 
 
C/ART- C/M+ 1142.314 509.6210 0.031251 108.75 2175.873 
{1}-{4} 
 
C/ART- ART+/M+ 991.141 509.6210 0.059636 -42.42 2024.701 
{2}-{3} 
 
C/ART+ C/M+ -567.205 509.6210 0.273088 -1600.76 466.355 
{2}-{4} 
 
C/ART+ ART+/M+ -718.377 509.6210 0.167230 -1751.94 315.182 
{3}-{4} 
 
C/M+ ART+/M+ -151.173 509.6210 0.768448 -1184.73 882.387 
 
P-values for Figure 0.6: The area, diameter, perimeter and radius of the renal corpuscle 
differed significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Diameter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Renal Corpuscle" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00
% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 10.35700 3.058108 0.001724 4.1549 16.55913 
{1}-{3} 
 
C/ART- C/M+ 7.31875 3.058108 0.022039 1.1166 13.52088 
{1}-{4} 
 
C/ART- ART+/M+ 5.75510 3.058108 0.067952 -0.4470 11.95723 
{2}-{3} 
 
C/ART+ C/M+ -3.03824 3.058108 0.327096 -9.2404 3.16389 
{2}-{4} 
 
C/ART+ ART+/M+ -4.60190 3.058108 0.141095 -10.8040 1.60023 
{3}-{4} 
 
C/M+ ART+/M+ -1.56365 3.058108 0.612253 -7.7658 4.63848 
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P-values for Figure 0.7: The area, diameter, perimeter and radius of the renal corpuscle 
differed significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Perimeter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Renal Corpuscle" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 32.5329 9.476150 0.001516 13.3143 51.75139 
{1}-{3} 
 
C/ART- C/M+ 22.0288 9.476150 0.025846 2.8103 41.24734 
{1}-{4} 
 
C/ART- ART+/M+ 19.0597 9.476150 0.051823 -0.1589 38.27819 
{2}-{3} 
 
C/ART+ C/M+ -10.5041 9.476150 0.275008 -29.7226 8.71447 
{2}-{4} 
 
C/ART+ ART+/M+ -13.4732 9.476150 0.163690 -32.6917 5.74532 
{3}-{4} 
 
C/M+ ART+/M+ -2.9692 9.476150 0.755839 -22.1877 16.24937 
 
P-values for Figure 0.8: The area, diameter, perimeter and radius of the renal corpuscle 
differed significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Radius (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Renal Corpuscle" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 5.17850 1.515774 0.001588 2.10437 8.252630 
{1}-{3} 
 
C/ART- C/M+ 3.65938 1.515774 0.020980 0.58524 6.733509 
{1}-{4} 
 
C/ART- ART+/M+ 3.15234 1.515774 0.044735 0.07820 6.226470 
{2}-{3} 
 
C/ART+ C/M+ -1.51912 1.515774 0.322932 -4.59325 1.555012 
{2}-{4} 
 
C/ART+ ART+/M+ -2.02616 1.515774 0.189702 -5.10029 1.047972 
{3}-{4} 
 
C/M+ ART+/M+ -0.50704 1.515774 0.739937 -3.58117 2.567093 
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P-values for Figure 0.9: The area, diameter, and radius of the glomerulus differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Area (Spreadsheet in Kidney data final.stw) Simultaneous 
confidence intervals Effect: Treatment Include condition: V4="Glomerulus" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 841.725 363.5612 0.026414 104.39 1579.061 
{1}-{3} 
 
C/ART- C/M+ -6.997 363.5612 0.984752 -744.33 730.340 
{1}-{4} 
 
C/ART- ART+/M+ 11.248 363.5612 0.975489 -726.09 748.585 
{2}-{3} 
 
C/ART+ C/M+ -848.722 363.5612 0.025267 -1586.06 -111.385 
{2}-{4} 
 
C/ART+ ART+/M+ -830.477 363.5612 0.028355 -1567.81 -93.140 
{3}-{4} 
 
C/M+ ART+/M+ 18.245 363.5612 0.960253 -719.09 755.581 
 
P-values for Figure 0.10: The area, diameter and radius of the glomerulus differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Diameter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Glomerulus" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 6.16025 2.896538 0.040363 0.2858 12.03470 
{1}-{3} 
 
C/ART- C/M+ -0.34540 2.896538 0.905744 -6.2198 5.52905 
{1}-{4} 
 
C/ART- ART+/M+ 0.20879 2.896538 0.942935 -5.6657 6.08324 
{2}-{3} 
 
C/ART+ C/M+ -6.50564 2.896538 0.030934 -12.3801 -0.63119 
{2}-{4} 
 
C/ART+ ART+/M+ -5.95146 2.896538 0.047223 -11.8259 -0.07700 
{3}-{4} 
 
C/M+ ART+/M+ 0.55419 2.896538 0.849344 -5.3203 6.42864 
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P-values for Figure 0.11: The area, diameter and radius of the glomerulus differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Perimeter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Glomerulus" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 16.8921 17.53998 0.341941 -18.6806 52.46481 
{1}-{3} 
 
C/ART- C/M+ 9.1842 17.53998 0.603753 -26.3885 44.75697 
{1}-{4} 
 
C/ART- ART+/M+ 5.6470 17.53998 0.749354 -29.9258 41.21970 
{2}-{3} 
 
C/ART+ C/M+ -7.7078 17.53998 0.662967 -43.2806 27.86489 
{2}-{4} 
 
C/ART+ ART+/M+ -11.2451 17.53998 0.525510 -46.8178 24.32762 
{3}-{4} 
 
C/M+ ART+/M+ -3.5373 17.53998 0.841311 -39.1100 32.03546 
 
P-values for Figure 0.12: The area, diameter and radius of the glomerulus differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Radius (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Glomerulus" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 3.08012 1.438921 0.039154 0.16186 5.998391 
{1}-{3} 
 
C/ART- C/M+ -0.17270 1.438921 0.905135 -3.09097 2.745569 
{1}-{4} 
 
C/ART- ART+/M+ -0.57846 1.438921 0.690055 -3.49673 2.339809 
{2}-{3} 
 
C/ART+ C/M+ -3.25282 1.438921 0.029927 -6.17109 -0.334554 
{2}-{4} 
 
C/ART+ ART+/M+ -3.65858 1.438921 0.015447 -6.57685 -0.740314 
{3}-{4} 
 
C/M+ ART+/M+ -0.40576 1.438921 0.779567 -3.32403 2.512508 
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P-values for Figure 0.13: The area, diameter, perimeter and radius of the LPCT differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Area (Spreadsheet in Kidney data final.stw) Simultaneous 
confidence intervals Effect: Treatment Include condition: V4="Tubule 1 & 2 
& 3" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 408.849 137.5168 0.005232 129.952 687.7457 
{1}-{3} 
 
C/ART- C/M+ 254.706 137.5135 0.072208 -24.185 533.5959 
{1}-{4} 
 
C/ART- ART+/M+ 200.874 137.5135 0.152754 -78.016 479.7646 
{2}-{3} 
 
C/ART+ C/M+ -154.143 137.5168 0.269751 -433.040 124.7540 
{2}-{4} 
 
C/ART+ ART+/M+ -207.974 137.5168 0.139173 -486.871 70.9226 
{3}-{4} 
 
C/M+ ART+/M+ -53.831 137.5135 0.697763 -332.722 225.0589 
 
 
P-values for Figure 0.14: The area, diameter, perimeter and radius of the LPCT differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Diameter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Tubule 1 & 2 & 3" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 4.98580 1.645109 0.004500 1.64937 8.322238 
{1}-{3} 
 
C/ART- C/M+ 2.98114 1.645073 0.078309 -0.35523 6.317499 
{1}-{4} 
 
C/ART- ART+/M+ 2.66504 1.645073 0.113958 -0.67132 6.001402 
{2}-{3} 
 
C/ART+ C/M+ -2.00467 1.645109 0.230936 -5.34110 1.331769 
{2}-{4} 
 
C/ART+ ART+/M+ -2.32076 1.645109 0.166915 -5.65720 1.015672 
{3}-{4} 
 
C/M+ ART+/M+ -0.31610 1.645073 0.848706 -3.65246 3.020266 
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P-values for Figure 0.15: The area, diameter, perimeter and radius of the LPCT differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Perimeter (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Tubule 1 & 2 & 3" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 15.86502 5.364894 0.005453 4.9845 26.74553 
{1}-{3} 
 
C/ART- C/M+ 10.84465 5.364757 0.050715 -0.0356 21.72488 
{1}-{4} 
 
C/ART- ART+/M+ 8.46239 5.364757 0.123450 -2.4178 19.34262 
{2}-{3} 
 
C/ART+ C/M+ -5.02037 5.364894 0.355621 -15.9009 5.86014 
{2}-{4} 
 
C/ART+ ART+/M+ -7.40263 5.364894 0.176150 -18.2831 3.47788 
{3}-{4} 
 
C/M+ ART+/M+ -2.38226 5.364757 0.659659 -13.2625 8.49797 
 
 
P-values for Figure 0.16: The area, diameter, perimeter and radius of the LPCT differed 
significantly between the four treatment groups.  
 
Comparisons 
Cell {#1}-
{#2} 
LSD test; variable Radius (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment Include condition: 
V4="Tubule 1 & 2 & 3" 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
-95.00% 
Cnf.Lmt 
 
+95.00% 
Cnf.Lmt 
 
{1}-{2} 
 
C/ART- C/ART+ 2.49298 0.912873 0.009718 0.64159 4.344374 
{1}-{3} 
 
C/ART- C/M+ 1.49057 0.912839 0.111209 -0.36076 3.341892 
{1}-{4} 
 
C/ART- ART+/M+ 0.81550 0.912839 0.377593 -1.03582 2.666826 
{2}-{3} 
 
C/ART+ C/M+ -1.00241 0.912873 0.279457 -2.85381 0.848979 
{2}-{4} 
 
C/ART+ ART+/M+ -1.67748 0.912873 0.074389 -3.52887 0.173914 
{3}-{4} 
 
C/M+ ART+/M+ -0.67507 0.912839 0.464385 -2.52639 1.176259 
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P-values for Figure 0.17: Proximal tubule area differed significantly between the four 
treatment groups.  
 
Comparisons 
Cell {#1}-{#2} 
LSD test; variable tubule thickness (Spreadsheet395 in Kidney data 
final.stw) Simultaneous confidence intervals Effect: Treatment 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
{1}-{2} 
 
C/ART- C/ART+ 283.87 96.64 0.01 
{1}-{3} 
 
C/ART- C/M+ 220.57 96.63 0.03 
{1}-{4} 
 
C/ART- ART+/M+ 154.70 96.63 0.12 
{2}-{3} 
 
C/ART+ C/M+ -63.30 96.64 0.52 
{2}-{4} 
 
C/ART+ ART+/M+ -129.17 96.64 0.19 
{3}-{4} 
 
C/M+ ART+/M+ -65.87 96.64 0.50 
 
 
P-values for Figure 0.18: The renal space differed significantly between the four 
treatment groups 
 
Comparisons 
Cell {#1}-{#2} 
LSD test; variable Renal space (Spreadsheet in Kidney data final.stw) 
Simultaneous confidence intervals Effect: Treatment 
1st 
Mean 
 
2nd 
Mean 
 
Mean 
Differ. 
 
Standard 
Error 
 
p 
 
{1}-{2} 
 
C/ART- C/ART+ 867.79 287.89 0.00 
{1}-{3} 
 
C/ART- C/M+ 1149.31 287.89 0.00 
{1}-{4} 
 
C/ART- ART+/M+ 979.89 287.89 0.00 
{2}-{3} 
 
C/ART+ C/M+ 281.52 287.89 0.33 
{2}-{4} 
 
C/ART+ ART+/M+ 112.10 287.89 0.70 
{3}-{4} 
 
C/M+ ART+/M+ -169.42 287.89 0.56 
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APPENDIX 8 Pathology observed in the pancreas 
 
Rat number Treatment Pancreas 
  
Score Proteinaceous material 
94 C/ART- 0 0 
112 C/ART+ 0 0 
130 C/ART+ 0 0 
154 C/ART- 0 0 
160 C/ART+ 0 0 
166 C/ART+ 0 0 
172 C/ART- 0 0 
190 ART+/M+ 0 0 
196 ART+/M+ 0 0 
202 ART+/M+ 0 0 
208 ART+/M+ 0 0 
214 ART+/M+ 0 0 
238 C/ART- 0 0 
256 C/ART- 0 0 
280 C/ART+ 0 0 
292 C/ART+ 0 0 
304 C/ART- 0 0 
310 C/M+ 0 0 
316 C/M+ 0 0 
322 C/M+ 0 0 
328 C/M+ 0 1 
343 C/M+ 0 0 
349 C/M+ 0 0 
355 C/M+ 0 0 
361 C/M+ 0 0 
1573 C/ART- 0 0 
1578 C/M+ 0 1 
1583 C/ART- 0 0 
1593 C/ART- 0 0 
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1603 ART+/M+ 0 0 
1608 C/ART+ 0 0 
1621 C/ART+ 0 0 
1626 C/ART+ 0 0 
1636 C/ART+ 0 0 
1646 ART+/M+ 0 0 
1656 ART+/M+ 0 0 
1661 ART+/M+ 0 0 
1666 C/M+ 0 0 
1671 ART+/M+ 0 0 
1681 C/ART+ 0 0 
Total 0 2 
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APPENDIX 9 Pathology observed in the liver 
 
Rat 
number 
Treatment Liver 
  
Score Granular 
appearance 
Loss of 
hepatocyte 
architechture 
Lymphocyte 
infiltration 
Vacuolation 
94 C/ART- 1 1 0 0 1 
112 C/ART+ 0 0 0 0 0 
130 C/ART+ 0 0 0 0 0 
154 C/ART- 0 0 0 0 0 
160 C/ART+ 0 0 0 0 0 
166 C/ART+ 1 0 1 0 0 
172 C/ART- 0 0 0 0 0 
190 ART+/M+ 0 0 0 0 0 
196 ART+/M+ 0 0 0 0 0 
202 ART+/M+ 0 0 0 0 0 
208 ART+/M+ 0 0 0 0 0 
214 ART+/M+ 0 0 0 0 0 
238 C/ART- 0 0 0 0 1 
256 C/ART- 0 0 0 0 1 
280 C/ART+ 0 0 0 0 0 
292 C/ART+ 0 0 0 0 0 
304 C/ART- 0 0 0 0 0 
310 C/M+ 0 0 0 0 0 
316 C/M+ 0 0 0 0 0 
322 C/M+ 1 0 0 1 0 
328 C/M+ 1 1 0 0 0 
343 C/M+ 0 0 0 0 0 
349 C/M+ 0 0 0 0 0 
355 C/M+ 0 0 0 0 0 
361 C/M+ 0 0 0 0 0 
1573 C/ART- 1 1 0 0 0 
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1578 C/M+ 1 1 0 0 1 
1583 C/ART- 1 1 0 0 0 
1593 C/ART- 1 1 0 0 1 
1603 ART+/M+ 1 1 0 0 0 
1608 C/ART+ 0 0 0 0 0 
1621 C/ART+ 0 0 0 0 0 
1626 C/ART+ 1 1 0 0 1 
1636 C/ART+ 1 1 0 0 0 
1646 ART+/M+ 0 0 0 0 0 
1656 ART+/M+ 0 0 0 0 0 
1661 ART+/M+ 0 0 0 0 0 
1666 C/M+ 0 0 0 0 0 
1671 ART+/M+ 0 0 0 0 0 
1681 C/ART+ 0 0 0 0 0 
Total 11 9 1 1 6 
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APPENDIX 10 Pathology observed in the kidney 
 
Rat number Treatment Kidney 
  
Score Swelling Vacuolation 
94 C/ART- 0 0 0 
112 C/ART+ 0 0 0 
130 C/ART+ 1 1 0 
154 C/ART- 0 0 0 
160 C/ART+ 0 0 0 
166 C/ART+ 0 0 0 
172 C/ART- 0 0 0 
190 ART+/M+ 1 1 1 
196 ART+/M+ 1 1 1 
202 ART+/M+ 1 1 1 
208 ART+/M+ 1 1 1 
214 ART+/M+ 1 1 1 
238 C/ART- 0 0 0 
256 C/ART- 1 1 1 
280 C/ART+ 1 1 0 
292 C/ART+ 1 0 1 
304 C/ART- 1 1 1 
310 C/M+ 1 1 1 
316 C/M+ 1 1 1 
322 C/M+ 1 1 1 
328 C/M+ 1 0 1 
343 C/M+ 0 0 0 
349 C/M+ 0 0 0 
355 C/M+ 1 1 1 
361 C/M+ 1 1 1 
1573 C/ART- 1 0 2 
1578 C/M+ 1 1 1 
1583 C/ART- 1 1 2 
1593 C/ART- 0 0 0 
Stellenbosch University  https://scholar.sun.ac.za
126 
 
1603 ART+/M+ 0 0 0 
1608 C/ART+ 1 0 1 
1621 C/ART+ 1 1 1 
1626 C/ART+ 0 0 0 
1636 C/ART+ 0 0 0 
1646 ART+/M+ 1 0 1 
1656 ART+/M+ 0 0 0 
1661 ART+/M+ 1 1 1 
1666 C/M+ 0 0 0 
1671 ART+/M+ 0 0 0 
1681 C/ART+ 1 0 1 
Total 24 18 22 
 
 
Stellenbosch University  https://scholar.sun.ac.za
